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Copper- and Cobalt-Catalyzed Syntheses of Thiophene-Based 
Tertiary Amines 
Salima Bouarfa,[a,b] Simon Graβl,[c] Maria Ivanova,[c] Timothy Langlais,[a,c] Ghenia Bentabed-Ababsa,*[b] 
Frédéric Lassagne,[a] William Erb,[a] Thierry Roisnel,[a] Vincent Dorcet,[a] Paul Knochel*[c] and Florence 
Mongin*[a] 
 
Abstract: Thienylzinc halides and related compounds prepared by 
deprotonation followed by transmetalation were used in copper-
catalyzed amination using N-benzoyloxy secondary amines. By 
extending the reaction to 1,5-naphthyridine, it was showed that the 
competitive dimer formation observed in the case of thiophenes was 
linked with the low stability of some thienylamines rather than 
homocoupling. Interestingly, thienylzinc halides and related 
compounds prepared by transmetalation of thienylmagnesium 
halides, either prepared from their bromo-precursors or generated by 
deprotometalation, were satisfactorily employed in cobalt-catalyzed 
aminations. Finally, aminothiophenes were involved in copper-
catalyzed mono- and di-N-arylations, affording differently substituted 
di- and triphenylamines. 
Introduction 
Electron-rich thiophenes and related compounds are an 
important class of five-membered aromatic heterocycles, notably 
for various applications in the fields of medicinal chemistry and 
materials.[1] Thiophene for example is found in the skeleton of 
important pharmaceuticals such as duloxetine and olanzapine, 
which respectively target major depressive disorder and 
schizophrenia, and dorzolamide, an anti-glaucoma agent. The 
thiophene scaffold is also present in many organic materials 
among which we can cite light-emitting diodes, field effect 
transistors and solar cells.[1] To access these aforementioned 
scaffolds, the functionalization of thiophenes is in general 
preferred over cyclizations of suitable substrates. As a 
consequence, efficient methods to regio- and chemoselectively 
introduce substituents onto thiophenes and related compounds 
are required. 
From the perspective of the pharmaceutical industry, one 
current challenge of organic synthesis remains the introduction 
of amines into drug molecules, if possible through C-H bond 
activation, and more generally by formation of C-N bonds.[2] 
Heteroaromatic C(sp2)-N bonds can be formed by transition 
metal-catalyzed couplings from the corresponding halides,[3] 
either using palladium-[4] or copper-catalysts.[5] Two 
complementary approaches have since been developed for the 
direct functionalization of heteroarenes,[6] oxidative reactions in 
the presence of a suitable metal catalyst-oxidant combination,[7] 
and transition metal-catalyzed electrophilic amination 
reactions.[8] 
Among the methods used to introduce aliphatic amines onto 
thiophenes, the oxidative nucleophilic substitution of hydrogen 
has been described but remains limited to specific nitro 
compounds;[9] therefore, most of the studies follow one of the 
above-mentioned strategies. Zinc amidocuprates formed from 
thienylzincs and lithium amides were involved in copper(I)-
mediated oxidative aminations.[10] Owing to a picolinamide 
directing group, morpholine can be introduced onto thiophene in 
the presence of a copper(II)-catalyst and PhI(OAc)2 as 
oxidant.[11] The in situ formation of diaryl-λ3-iodanes followed by 
copper(I)-catalyzed reaction with morpholine can be similarly 
applied to thiophene in average yields.[12] Provided that a 
carboxamide group is present, ruthenium(II)-catalyzed C-H 
amination of thiophenes can be performed with N-
(benzoyloxy)morpholine in moderate yields.[13] The use of O-
benzoyl hydroxylamines (BzO-NR2) to intercept thienylmetals 
under copper(I)-catalysis displays a broader substrate scope, 
and has been developed from arylmetals prepared by C-H 
lithiation-transalumination[14] and, above all, by 
deprotozincation.[15] 
If copper was employed as catalyst in the Johnson 
pioneered electrophilic amination of diarylzincs by BzO-NR2 in 
2004,[16] cobalt can also be used to catalyze amination of 
arylzincs.[8b] Indeed, we recently showed that both arylzinc 
pivalates[17] and chlorides[18] can be involved in such an 
amination in the presence of cobalt salts. In the present paper, 
we report our studies on copper- and cobalt-catalyzed reactions 
involving thienylzincs and O-benzoyl secondary hydroxylamines. 
Our investigations on the copper-catalyzed mono and double N-
arylation of thienylamines by aromatic iodides to access 
thiophene-based triarylamines are also presented. 
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Results and Discussion 
We first studied a ‘deprotolithiation-transmetalation to zinc-
copper catalyzed amination’ sequence in THF (THF = 
tetrahydrofuran) by starting from benzothiophene (Table 1). In 
order to generate the corresponding arylzinc halide, we 
compared two methods, (i) butyllithium-mediated 
deprotolithiation followed by transmetalation using 
ZnCl2·TMEDA
[19] (TMEDA = N,N,N’,N’-
tetramethylethylenediamine; entry 1) and (ii) deprotolithiation 
using LiTMP (TMP = 2,2,6,6-tetramethylpiperidino) in the 
presence of ZnCl2·TMEDA as in situ trap (entry 2).
[20] Amination 
was next performed by using N-(benzoyloxy)diallylamine and a 
catalytic amount of copper(II) acetate. Under these conditions, 
the expected product 1a was isolated in 51-52% yield in spite of 
its propensity to turn into 2,2’-bi(benzothiophene) (1’; entries 1 
and 2). These results suggest that lithium chloride and TMEDA, 
that are both present, do not hamper the reaction. In contrast, 
attempts to directly use benzothienyllithium (formed by reaction 
with LiTMP) instead of the corresponding zinc compound did not 
furnish 1a (entry 3). The presence of the electrophile and 
catalyst during the addition of the base to the substrate similarly 
failed (entry 4). N-(benzoyloxy)dibutylamine, N-
(benzoyloxy)morpholine and N-(benzoyloxy)piperidine were 
used under the best reaction conditions to afford the expected 
benzothienylamines 1b-d (entries 5-7; Figure 1, top). 
 
Table 1. Optimization of the conversion of benzothiophene into 2-benzothienylamines 1. 
 
Entry Base (equiv), conditions Product 1, Yield [%]
[a]
 
1 
1) BuLi (1), ‒20 °C, 0.5 h 
2) ZnCl2·TMEDA (1), ‒20 °C, 0.5 h 
 
1a, 51
[b]
 
2 
1) ZnCl2·TMEDA (1) 
2) LiTMP (1), ‒20 °C, 0.5 h 
1a, 52
[b]
 
3 LiTMP (1), ‒20 °C, 0.5 h 1a, 0
[c]
 
4 
LiTMP (1) added to the solution of benzothiophene, 
(allyl)2N-OCOPh and Cu(OAc)2 in THF, ‒20 °C, 0.5 h 
1a, 0
[d]
 
5 
1) BuLi (1), ‒20 °C, 0.5 h 
2) ZnCl2·TMEDA (1), ‒20 °C, 0.5 h 
 
1b, 63
[b]
 
6 
1) BuLi (1), ‒20 °C, 0.5 h 
2) ZnCl2·TMEDA (1), ‒20 °C, 0.5 h  
1c, 29
[b]
 
7 
1) BuLi (1), ‒20 °C, 0.5 h 
2) ZnCl2·TMEDA (1), ‒20 °C, 0.5 h  
1d, 68
[b]
 
[a] After purification (see experimental part). [b] 2,2’-Bi(benzothiophene) (1’) was detected in the crude and proved to be 
more or less difficult to separate, depending on both the polarity and the stability of the product 1. [c] Benzothiophene was 
present in the crude (<20% yield) together with an unidentified product, but 1’ was not detected. [d] Benzothiophene was 
present in the crude together with the same unidentified product. 
 
 
Scheme 1. Extension of the sequence to 2-chlorothiophene and proposed mechanism to rationalize the degradation of 2a. [a] 5,5’-
Dichloro-2,2’-bithiophene (2a’) was also isolated in 32% yield. 
    
 
 
 
 
 
When the reaction was extended to 2-chlorothiophene, we 
isolated both the expected diallylamine 2a in 49% yield and the 
dimer 2a’ in 32% yield (Scheme 1). Interestingly we observed 
that, upon storage in a fridge, isolated 2a turns dark blue in a 
few days (or in a few minutes if dissolved in chloroform) while it 
is converted into the dimer 2a’. This result tends to show that 
dimerization is not related to a side homocoupling taking place in 
the course of the reaction, but rather associated with the 
thienylamine instability.[21] We thus decided to move to a 
substrate for which the corresponding amines are stable. 
The 1,5-naphthyridine heterocycle is present in numerous 
compounds endowed with biological properties as well as in 
OLED materials.[22] Besides direct introduction of an amino 
group by a Chichibabin reaction,[23] its functionalization at C4 
can be achieved by deprotometalation. The latter was performed 
by using a lithium amide provided that a directing group is 
present at C3.[24] However, from bare 1,5-naphthyridine, a 
regioselective reaction at C4 was found possible after 
precomplexation of the substrate with (TMP)2Mg·2LiCl, and 
takes place in THF within 5 min at ‒78 °C.[22] In order to prepare 
amines (Table 2), we first evaluated the ‘deprotolithiation-
transmetalation to zinc-copper catalyzed amination’ sequence, 
successful from benzothiophene, by using N-
(benzoyloxy)diallylamine as electrophile. However, under these 
conditions, the expected amine 3a was isolated in a maximum 
10% yield (entries 1 and 2). In order to understand the reason of 
this failure, we tested iodine as electrophile, and obtained the 4-
iodo 3-I and 4,8-diiodo 3’-I in respective yields of 34 and 6% 
alongside with remaining starting material (Scheme 2, left). 
Concerned by the potential low stability of the intermediate 4-
lithio compound, we next moved to more stable zinc amides. 
After deprotozincation using TMPZnCl·LiCl[25] (1.1 equiv) at 
room temperature for 2 h, interception with N-
(benzoyloxy)diallylamine as before led to 3a in 64% yield (entry 
3), a rather good result since trapping with iodine afforded 3-I in 
72% yield (Scheme 2, left). (TMP)2Zn·2LiCl, prepared from 
LiTMP and ZnCl2 in a 2:1 ratio, was similarly employed and 
furnished the amine 3c after copper-catalyzed reaction with N-
(benzoyloxy)morpholine (entry 4). Interestingly, a magnesium 
intermediate generated by TMPMgCl·LiCl[26] is tolerated,[27] as 
evidenced by quenching with N-(benzoyloxy)diisopropylamine to 
afford the amine 3b in 52% yield (entry 5). 
Alternatively, the synthesis of the amines 3a-c can be 
considered by nucleophilic substitution of the iodo 3-I. If such a 
possibility efficiently worked by using morpholine as nucleophile, 
the yield dropped to 17% with diallylamine, and the reaction 
failed with diisopropylamine, a result probably due to important 
steric hindrance in this case (Scheme 2, right). Thus, 
deprotometalation-amination and deprotometalation-iodolysis-
substitution appear as being complementary to access 1,5-
naphthyridines 4-substituted by various amino groups. 
 
Table 2. Extension to 1,5-naphthyridine. 
 
Entry Base (equiv), conditions Product 3, Yield [%]
[a]
 
1 
1) ZnCl2·TMEDA (1) 
2) LiTMP (1.2), ‒30 °C, 0.5 h 
 
3a, 0
[b]
 
2
[c]
 
1) ZnCl2·TMEDA (1) 
2) LiTMP (2.2), ‒30 °C, 0.5 h 
3a, 10
[b]
 
3 TMPZnCl·LiCl (1.1), r.t., 2 h 3a, 64 
4 (TMP)2Zn·2LiCl (1.1), r.t., 2 h 
 
3c, 52 
5 TMPMgCl·LiCl (1.1), ‒40 °C, 1 h 
 
3b, 52 
[a] After purification (see experimental part). [b] The rest is starting material. [c] By using 2.2 equivalents of (allyl)2N-OCOPh. 
    
 
 
 
 
 
 
Scheme 2. Alternative way to access 1,5-naphthyridines 4-substituted by amino groups. [a] 4,8-Diiodo-1,5-naphthyridine (3’-I) was 
also isolated in 6% yield. 
We next involved thiophene-based and related organozinc 
chlorides in cobalt-catalyzed amination reactions. First, arylzinc 
compounds were prepared by transmetalation of the 
corresponding arylmagnesium reagents obtained by LiCl-
favored reactions: 2-thienyl- and 2-benzothienylmagnesium 
bromides by Grignard reaction (insertion method A;[28] Scheme 
3, top), and 2-thiazolyl- and 2-benzothiazolylmagnesium 
bromides by bromine/metal exchange (exchange method B,[29] 
bottom). The amination step was successfully performed to 
respectively afford 1c, 2c, 2e, 2f and 4c, 5e, 5f, 5g by using N-
(benzoyloxy) secondary amines in the presence of 
CoCl2·2LiCl,
[17] a combination that recently proved efficient to 
functionalize organozincs prepared from other aryl halides.[17-18]  
For atom economy reason and to avoid the use of costly aryl 
bromides, we finally employed organozinc compounds prepared 
by deprotometalation-transmetalation in this cobalt-catalyzed 
amination (Scheme 4). This represents an additional challenge 
as very few cobalt-catalyzed electrophilic trappings have been 
achieved from arylzincs prepared by deprotometalation.[30]  
To this purpose, we involved in the amination 2-thienylzinc 
chlorides prepared from 2,2’-bithiophene and thieno[3,2-
b]thiophene by deprotomagnesiation using TMPMgCl·LiCl[26,31] 
followed by transmetalation (top). Similarly, we performed the 
amination of the organozinc chloride coming from 1,3-dithiole-2-
thione, generated by using the same base at low temperature[32] 
followed by transmetalation (bottom). The reactions gave the 
expected amines 6c, 7c, 7f, 7h and 8c, 8e, 8f, 8h in high yields 
in the presence of TMEDA (0.2 equiv),[17] making this cobalt-
catalyzed ‘deprotonation-transmetalation-amination’ a general 
way to obtain amino-substituted thiophenes and related 
compounds. 
 
 
Scheme 3. Cobalt-catalyzed amination of (benzo)thienylzinc and (benzo)thiazolylzinc chlorides prepared from the corresponding 
halides. [a] Yields are given after purification (see experimental part). 
    
 
 
 
 
 
 
Scheme 4. Cobalt-catalyzed amination of organozinc chlorides prepared by deprotonation-transmetalation. [a] Yields are given after 
purification (see experimental part). 
 
Figure 1. ORTEP diagrams (50% probability) of the compounds 1d and 10ab. 
Apart from nucleophilic substitution reactions that require 
activated aryl halides and strong reaction conditions,[33] access 
to thiophene-based triarylamines is more readily possible by 
applying the Buchwald-Hartwig approach. Thus, palladium-
catalyzed reactions have been used to N-arylate 2-amino-[33a,34] 
and 3-amino-[35] thiophenes or benzothiophenes. To avoid the 
use of expensive transition metal, and following our interest in N-
arylation reactions,[36] we next investigated the copper-catalyzed 
N-arylation of thiophene-based anilines. Indeed, if copper has 
been employed to catalyze N-arylation of an aminothiophene 
with organoboron reagents,[37] aryl halides have to our 
knowledge never been used in such reactions.  
We recently reported the use of 2-aminophenones as 
substrates in copper-catalyzed N-arylation with aryl and 
heteroaryl iodides.[36d] To achieve the reactions, we employed a 
catalytic amount of activated copper and potassium carbonate 
as a base at the reflux temperature of dibutylether. We chose 
these conditions as starting point to investigate the reaction from 
methyl 3-amino-2-thiophenecarboxylate and methyl 2-amino-3-
thiophenecarboxylate. Preliminary results led us to rapidly 
realize that reproducibility of the reactions could be ensured by 
using stoichiometric copper (5 x 0.2 equiv added every 2 h), 
conditions that were kept to perform the whole study. 
When methyl 3-amino-2-thiophenecarboxylate (Scheme 5) 
was treated by 1.5 equivalents of iodobenzene, a mixture of the 
mono- and diphenylated products 9a and 10a was formed in a 
~1:1 ratio under these conditions. By reducing the amount of aryl 
iodide to one equivalent, monoarylation was favored, affording 
9a in 79% yield; only traces of 10a were observed in the crude, 
and could be easily removed by purification over silica gel (top). 
Conversely, increasing the amount of iodide to 2 equivalents 
allowed 10a to be obtained in a high 88% yield; using 3-
iodothiophene instead of iodobenzene similarly furnished 10d 
(bottom left). 
The formation of the monophenylated 9a in high yield using 
1 equivalent of iodide shows that 9a is less reactive than starting 
3-amino-2-thiophenecarboxylate in the N-arylation reaction. It is 
nevertheless possible, by using an excess of the iodide, to 
prepare triarylamines, as shown with the products 10a and 10d. 
Furthermore, a different aryl iodide could be used in the second 
N-arylation reaction and, when 9a was treated by 4-iodoanisole 
and 1-iodo-4-(trifluoromethyl)benzene under the same reaction 
conditions, the differently substituted triarylamines 10ab (Figure 
1, bottom) and 10ac were isolated in high yields (bottom right). 
    
 
 
 
 
 
 
 
Scheme 5. N-arylation of methyl 3-amino-2-thiophenecarboxylate to afford either 9 or 10. [a] Added by portions of 0.2 equivalent 
every 2 h. [b] After purification (see experimental part). 
 
Scheme 6. Compared reactivities of 4-iodoanisole and 1-iodo-4-(trifluoromethyl)benzene in the N-arylation of 9a. 
A competitive reaction performed on 9a in the presence of 
two halides, 4-iodoanisole and 1-iodo-4-(trifluoromethyl)benzene, 
showed close reactivities, but in favor of more electron-rich 4-
iodoanisole (Scheme 6). When compared with works on both the 
Goldberg reaction[38] and the copper-catalyzed N-arylation of 
aniline with aryl bromides,[39] in which electron-withdrawing 
substituents at the para position of the aryl halide facilitate the 
reaction rates, our competition study revealed a different 
behavior for the 4-trifluoromethylated iodide. 
We next turned to the isomeric methyl 2-amino-3-
thiophenecarboxylate (Scheme 7). As observed for methyl 3-
amino-2-thiophenecarboxylate, reaction with 1.5 equivalents of 
iodobenzene under the same reaction conditions led to a 
mixture of the mono- and diphenylated products 11a and 12a in 
respective yields of 59% and 30%. It proved easy to achieve 
monophenylation by using 1 equivalent of iodobenzene (83% 
yield; top). Though somewhat less efficient, diphenylation was 
also possible (54% and 76% yield, respectively using 
iodobenzene and 3-iodothiophene; bottom left). The N-arylation 
of 11a with 4-iodoanisole and 2-iodobenzofuran satisfactorily led 
to two new thiophene-based triarylamines (bottom right). 
We finally compared the reactivity of 2-aminothiophenes and 
3-aminothiophenes in this N-arylation reaction (Scheme 8). To 
this purpose, we chose 4-iodoanisole to first attempt a 
competitive reaction between methyl 3-amino-2-
thiophenecarboxylate and methyl 2-amino-3-
thiophenecarboxylate (left). Even if the former also reacted, we 
noticed a higher reactivity of the latter (a ~1:3 ratio was 
recorded). As monophenylated 9a and 11a are less reactive 
than their precursors (at the origin of the possible monoarylation 
reactions), this reactivity difference towards 4-iodoanisole is 
logically more pronounced between less reactive 9a and 11a 
(right). It is difficult to rationalize such a reactivity difference, but 
more studies will be performed in order to get general trends 
and connect them with possible reaction mechanisms. 
    
 
 
 
 
 
 
 
 
Scheme 7. N-arylation of methyl 2-amino-3-thiophenecarboxylate to afford either 11 or 12. [a] Added by portions of 0.2 equivalent 
every 2 h. [b] The diphenylated product 12a was also isolated in 6% yield. [c] After purification (see experimental part). [d] Starting 
iodide and benzofuran were present in the crude, but no more aminothiophene. 
 
Scheme 8. Left: Compared reactivities of methyl 3-amino-2-thiophenecarboxylate and methyl 2-amino-3-thiophenecarboxylate in the 
N-arylation using 4-iodoanisole. Right: Compared reactivities of methyl 3-(phenylamino)-2-thiophenecarboxylate (9a) and methyl 2-
(phenylamino)-3-thiophenecarboxylate (11a) in the N-arylation using 4-iodoanisole. 
 
    
 
 
 
 
 
Conclusions 
In the course of this study dedicated to the synthesis of 
thiophene-based tertiary amines, we have developed three 
approaches that are copper-catalyzed and cobalt-catalyzed 
amination of thienylzinc halides or related compounds, and 
copper-catalyzed arylation of aminothiophenes. The amination 
allowed thienylzinc halides, obtained by bromine/metal 
exchange but also by deprotometalation, to be functionalized; 
the only limit seems to be the low stability of some of the 
generated thienylamines. Concerning copper-catalyzed N-
arylation of aminothiophenes, a single reaction can be 
selectively achieved, but also diarylation using two different aryl 
iodides. Such reactions will undoubtly find applications given the 
interest for thiophenes and related compounds in the fields of 
medicinal chemistry and materials. 
Experimental Section 
General 
All reactions were carried out under an argon atmosphere in flame-dried 
glassware. Syringes, which were used to transfer anhydrous solvents or 
reagents, were purged with argon prior to use. THF was continuously 
refluxed and freshly distilled from sodium-benzophenone under nitrogen 
or argon and stored over molecular sieves. Column chromatography 
separations were achieved on silica gel (40-63 μm) from Merck. Melting 
points were measured on a Kofler apparatus. IR spectra were taken on a 
Perkin-Elmer Spectrum 100 spectrometer. 1H and 13C Nuclear Magnetic 
Resonance (NMR) spectra were recorded either on a Bruker Avance III 
spectrometer at 300 MHz and 75 MHz respectively, or on a Bruker ARX-
400 spectrometer at 400 MHz and 101 MHz respectively. 1H chemical 
shifts (δ) are given in parts per million (ppm) relative to the solvent 
residual peak and 13C chemical shifts are relative to the central peak of 
the solvent signal.[40] Mass spectra and high resolution mass spectra 
(HRMS) were recorded using electron ionization (EI) except otherwise 
noted. Gas-chromatographical analyses were performed on machines of 
the types Hewlett-Packard 6890 or 5890 Series II (Hewlett Packard, 5% 
phenylmethylpolysiloxane; length: 10 m, diameter: 0.25 mm; film 
thickness: 0.25 μm). 
Starting materials 
iPrMgCl·LiCl was purchased as a solution in THF from Albemarle and 
titrated against iodine prior to use.[41] 
ZnCl2 solution (1.0 M in THF) was prepared by drying ZnCl2 (136 g, 
0.10 mol) in a Schlenk-flask under vacuum at 140 °C for 5 h. After 
cooling, dry THF (100 mL) was added and stirring was continued until all 
salts were dissolved (12 h). ZnCl2·TMEDA was prepared as reported 
previously.[19a] 
After opening a new bottle of 2,2,6,6-tetramethylpiperidine, KOH pellets 
were added and storage in a desiccator was necessary. LiTMP was 
prepared by adding BuLi (about 1.6 M hexanes solution, 1.5 mmol) to a 
stirred, cooled (‒10 °C) solution of 2,2,6,6-tetramethylpiperidine (0.28 mL, 
1.7 mmol) in THF (3 mL) and stirring for 5 min. If necessary, the solution 
was titrated as reported previously.[26] 
TMPZnCl·LiCl was prepared as follows.[25] A dry and argon flushed 
250 mL Schlenk flask, equipped with a magnetic stirrer and a septum, 
was charged with 2,2,6,6-tetramethylpiperidine (10.2 mL, 60 mmol) and 
THF (60 mL). The solution was cooled to ‒40 °C before dropwise 
addition of BuLi (2.4 M in hexane, 25 mL, 60 mmol). Then, the reaction 
mixture was allowed to warm up slowly to ‒10 °C for 1 h. ZnCl2 (1.0 M in 
THF, 66 mL, 66 mmol) was added dropwise and the resulting solution 
was stirred for 0.5 h at ‒10 °C and then for 0.5 h at 25 °C. The solvents 
were then removed under vacuum to afford a yellowish solid. Freshly 
distilled THF was then slowly added under vigorous stirring until the salts 
were completely dissolved. The freshly prepared TMPZnCl·LiCl solution 
was titrated prior to use at 25 °C with benzoic acid using 4-
(phenylazo)diphenylamine1 as indicator.[42] 
(TMP)2Zn·2LiCl was prepared as follows in a nearly quantitative yield. A 
dry and argon flushed 250 mL Schlenk flask, equipped with a magnetic 
stirrer and a septum, was charged with 2,2,6,6-tetramethylpiperidine 
(10.2 mL, 60 mmol) and THF (60 mL). The solution was cooled to ‒40 °C 
before dropwise addition of BuLi (2.4 M in hexane, 25 mL, 60 mmol). 
Then, the reaction mixture was allowed to warm up slowly to ‒10 °C for 
1 h. ZnCl2 (1.0 M in THF, 30 mL, 30 mmol) was added dropwise and the 
resulting solution was stirred for 0.5 h at ‒10 °C and then for 0.5 h at 
25 °C. The solvents were then removed under vacuum. Freshly distilled 
THF was then slowly added to the residue under vigorous stirring until 
the salts were completely dissolved and an orange solution obtained. 
TMPMgCl·LiCl was prepared as follows.[26] In a dry and argon flushed 
Schlenk-flask, 2,2,6,6-tetramethylpiperidine (14.8 g, 105 mmol) was 
added to iPrMgCl·LiCl (71.4 mL, 0.10 mol, 1.4 M in THF) at 25 °C and 
the mixture was stirred for 3 days at 25 °C. The freshly prepared 
TMPMgCl·LiCl was titrated prior to use at 0 °C with benzoic acid using 4-
(phenylazo)diphenylamine as indicator.[42] 
CoCl2·2LiCl was prepared as follows.
[17] A dry and argon-flushed 250 mL 
Schlenk-flask, equipped with a magnetic stirring bar and a rubber septum, 
was charged with anhydrous LiCl (5.9 g, 0.14 mol) and heated to 150 °C 
under high vacuum for 5 h. After cooling to room temperature under 
vacuum, anhydrous CoCl2 (9.1 g, 70 mmol) was added under argon. The 
Schlenk-flask was further heated to 130 °C for 3 h under high vacuum, 
cooled to 25 °C and charged with dry THF (70 mL). The mixture was 
vigorously stirred until all solids were dissolved (ca. 8 h). The reagent 
CoCl2·2LiCl (1 M in THF) is obtained as a dark blue solution. 
1,5-Naphthyridine,[22] activated Cu,[43] methyl (2-aminothiophene-3-
carboxylate[44] and 2-iodobenzofuran[45] were prepared as reported 
previously. 
All reagents not listed in the publication (main paper or supporting 
information) were obtained from commercial sources. 
Crystallographic data 
CCDC 1896366 (1d), 1896367 (2a’) and 1896368 (10ab) contain the 
crystallographic data for this paper. These data can be obtained free of 
charge from The Cambridge Crystallographic Data Centre. 
The samples were studied with monochromatized Mo-K radiation ( = 
0.71073 Å, multilayer monochromator). The X-ray diffraction data of the 
compounds 1d, 2a’ and 10ab were collected at 150(2)  K by using a D8 
VENTURE Bruker AXS diffractometer equipped with a (CMOS) PHOTON 
    
 
 
 
 
 
100 detector. The structure was solved by dual-space algorithm using the 
SHELXT program,[46] and then refined with full-matrix least-square 
methods based on F2 (SHELXL-2014).[47] All non-hydrogen atoms were 
refined with anisotropic atomic displacement parameters. H atoms were 
finally included in their calculated positions and treated as riding on their 
parent atom with constrained thermal parameters. The molecular 
diagrams were generated by ORTEP-3 (version 2.02).[48] 
General procedure 1 for the N-benzoyloxylation of secondary 
amines. 
To dibasic potassium phosphate (K2HPO4; 1.3 g, 7.5 mmol) and freshly 
dried benzoyl peroxide (1.2 g, 5.0 mmol) in DMF (20 mL) under argon 
was slowly added the secondary amine (6.0 mmol). The reaction mixture 
was stirred at room temperature until disappearance of benzoyl peroxide 
(about 12 h, as shown by TLC monitoring). After addition of saturated 
aqueous ammonium chloride (30 mL), extraction was performed using 
AcOEt (3x20 mL). The organic phase was washed with saturated 
aqueous NaHCO3 (20 mL) and brine (20 mL), and then dried over 
Na2SO4. Removal of the solvent and purification by chromatography on 
silica gel (the eluent is given in the product description) led to the 
expected compound. 
N-(Benzoyloxy)diallylamine. 
The general procedure 1 using diallylamine (0.74 mL) gave N-
(benzoyloxy)diallylamine (eluent: hexanes-AcOEt 80:20; Rf = 0.67) in 
76% yield (0.83 g) as a yellow oil. 1H NMR (300 MHz, CDCl3)  3.39 (d, 
2H, J = 6.5 Hz), 4.90 (dd, 2H, J = 10.2 and 1.6 Hz), 5.00 (dd, 2H, J = 
17.2 and 1.6 Hz), 5.76 (ddt, 2H, J = 16.8, 10.1 and 6.5 Hz), 7.12 (dd, 2H, 
J = 8.3 and 6.9 Hz), 7.24 (tt, 1H, J = 7.4 and 1.9 Hz), 7.72 (dd, 2H, J = 
8.3, 1.4 Hz). The analyses are as described previously.[17] 13C NMR (75 
MHz, CDCl3)  61.7 (2CH2), 119.5 (2CH2), 128.3 (2CH), 129.2 (C), 129.4 
(2CH), 132.5 (2CH), 133.0 (CH), 165.3 (C, C=O). 
N-(Benzoyloxy)dibutylamine. 
The general procedure 1 using dibutylamine (1.01 mL) gave N-
(benzoyloxy)dibutylamine (eluent: hexanes-AcOEt 95:5; Rf = 0.62) in 
59% yield (0.74 g) as a colorless oil. 1H NMR (300 MHz, CDCl3)  0.86 (t, 
3H, J = 7.3 Hz), 1.34 (sext, 2H, J = 7.3 Hz), 1.54 (ddd, 2H, J = 15.1, 8.7 
and 6.1 Hz), 2.92 (d, 1H, J = 7.4 Hz), 2.94 (d, 1H, J = 7.4 Hz), 7.39 (t, 2H, 
J = 7.4 Hz), 7.51 (tt, 1H, J = 7.4 and 1.9 Hz), 7.99 (d, J = 7.1 Hz, 1H). 
The 1H NMR data are as described previously.[49] 13C NMR (75 MHz, 
CDCl3)  13.9 (2CH3), 20.5 (2CH2), 29.0 (2CH2), 59.5 (2CH2), 128.4 
(2CH), 129.4 (C), 129.5 (2CH), 132.9 (CH), 165.6 (C, C=O). 
N-(Benzoyloxy)morpholine. 
The general procedure 1 using morpholine (0.52 mL) gave N-
(benzoyloxy)morpholine (eluent: hexanes-AcOEt 50:50; Rf = 0.62) in 
37% yield (0.39 g) as a white powder: mp 82 °C (lit.[50] 81-82 °C); IR 
(ATR): 677, 708, 793, 857, 1008, 1023, 1049, 1066, 1083, 1100, 1247, 
1316, 1386, 1453, 1600, 1728, 2849, 2966 cm-1; 1H NMR (300 MHz, 
CDCl3)  2.99-3.01 (m, 2H), 3.39-3.41 (m, 2H), 3.78-3.91 (m, 4H), 7.40 (t, 
2H, J = 7.6 Hz), 7.52 (t, 1H, J = 7.3 Hz), 7.97 (d, 2H, J = 7.2 Hz). 13C 
NMR (75 MHz, CDCl3)  56.9 (2CH2), 65.8 (2CH2), 128.4 (2CH), 129.0 
(C), 129.4 (2CH), 133.2 (CH), 164.5 (C, C=O). 
N-(Benzoyloxy)piperidine. 
The general procedure 1 using piperidine (0.59 mL) gave N-
(benzoyloxy)piperidine (eluent: hexanes-AcOEt 70:30; Rf = 0.75) in 64% 
yield (0.66 g) as a beige powder: mp 65 °C (lit.[50] 62.5-63 °C); IR (ATR): 
428, 675, 713, 782, 850, 917, 1019, 1037, 1070, 1092, 1184, 1235, 1249, 
1270, 1280, 1319, 1453, 1601, 1728, 2847, 2940 cm-1; 1H NMR (300 
MHz, CDCl3)  1.00-1.59 (m, 6H), 2.55 (br s, 2H), 3.28 (br s, 2H), 7.18 (t, 
2H, J = 7.7 Hz), 7.30 (t, 1H, J = 7.3 Hz), 7.79 (d, 2H, J = 7.8 Hz). 
N-(Benzoyloxy)diisopropylamine. 
The general procedure 1 using diisopropylamine (0.84 mL) gave N-
(benzoyloxy)diisopropylamine (eluent: hexanes-AcOEt 90:10; Rf = 0.30) 
in 45% yield (0.50 g) as a yellow oil: IR (ATR): 644, 663, 708, 729, 874, 
913, 1025, 1061, 1081, 1177, 1243, 1314, 1383, 1451, 1601, 1740, 2226, 
2877, 2938, 2978 cm-1; 1H NMR (300 MHz, CDCl3)  1.03 (d, 12H, J = 
6.3 Hz), 3.28 (hept, 2H, J = 6.2 Hz), 7.31 (t, 2H, J = 7.3 Hz), 7.43 (t, 1H, J 
= 7.3 Hz), 7.91 (d, 2H, J = 7.7 Hz). The NMR data are as described 
previously.[51] 13C NMR (75 MHz, CDCl3)  17.2 (br s, 2CH3), 20.1 (br s, 
2CH3), 53.3 (2CH), 128.3 (2CH), 129.1 (C), 129.3 (2CH), 132.8 (CH), 
166.1 (C, C=O). 
N-(Benzoyloxy)di(2-methoxyethyl)amine. 
The general procedure 1 using di(2-methoxyethyl)amine (0.89 mL) gave 
N-(benzoyloxy)di(2-methoxyethyl)amine (eluent: hexanes-AcOEt 50:50) 
in 76% yield (0.96 g) as a colorless oil: IR (ATR): 1022, 1056, 1116, 1198, 
1241, 1450, 1740, 2888 cm-1; 1H NMR (400 MHz, CDCl3)  3.26 (t, 4H, J 
= 5.6 Hz), 3.29 (s, 6H), 3.61 (t, 4H, J = 5.8 Hz), 7.43-7.45 (m, 2H), 7.57 (t, 
1H, J = 7.4 Hz), 8.02 (dd, 2H, J = 8.3 and 1.2 Hz); 13C NMR (101 MHz, 
CDCl3)  59.0 (2CH3), 59.4 (2CH2), 69.9 (2CH2), 128.5 (2CH), 129.6 (C), 
129.7 (2CH), 133.2 (CH), 165.6 (C, C=O); MS (EI, 70 eV) m/z (%) 42 
(87), 44 (36), 51 (10), 56 (10), 59 (13), 76 (37), 88 (16), 104 (100), 105 
(11), 121 (19), 208 (29); HRMS (EI) m/z calcd for C13H19NO4: 253.1314; 
found: 253.1307. 
N-(Benzoyloxy)-1,4-dioxa-8-azaspiro[4.5]decane. 
The general procedure 1 using 1,4-dioxa-8-azaspiro[4.5]decane 
(0.77 mL) gave N-(benzoyloxy)-1,4-dioxa-8-azaspiro[4.5]decane (eluent: 
hexanes-AcOEt 50:50) in 71% yield (0.93 g) as a white solid: IR (ATR): 
1060, 1081, 1122, 1245, 1447, 1733, 2959 cm-1; 1H NMR (400 MHz, 
CDCl3)  1.97 (t, 4H, J = 5.7 Hz), 3.27 (br s, 2H), 3.45 (br s, 2H), 4.00 (s, 
4H, OCH2CH2O), 7.44 (t, 2H, J = 7.5 Hz), 7.57 (t, 1H, J = 7.5 Hz); 
13C 
NMR (101 MHz, CDCl3)  32.8 (2CH2), 54.1 (2CH2), 64.6 (2CH2), 106.3 
(C), 128.5 (2CH), 129.6 (2CH), 129.6 (C), 133.1 (CH), 164.9 (C, C=O). 
The NMR data are as described previously.[52] MS (EI, 70 eV) m/z (%) 42 
(11), 43 (100), 45 (14), 50 (14), 61 (12), 77 (49), 88 (11), 87 (13), 122 
(55); HRMS (EI) m/z calcd for C14H17NO4: 263.1158; found: 263.1156.  
N-(Benzoyloxy)azepane. 
The general procedure 1 using azepane (0.68 mL) gave N-
(benzoyloxy)azepane as reported previously.[53] 1H NMR (400 MHz, 
CDCl3)  1.68 (dt, 4H, J = 6.1 and 3.0 Hz), 1.82 (ddd, 4H, J = 6.8, 4.4 and 
1.8 Hz), 3.33 (t, 4H, J = 5.5 Hz), 7.43 (t, 2H, J = 7.7 Hz), 7.55 (t, 1H, J = 
7.4 Hz), 8.00 (dd, 2H, J = 8.3 and 1.4 Hz); 13C NMR (101 MHz, CDCl3)  
24.2 (2CH2), 26.5 (2CH2), 59.6 (2CH2), 128.5 (2CH), 129.5 (2CH), 129.8 
(C), 133.0 (CH), 164.9 (C, C=O). 
N-(Benzoyloxy)-1,2,3,4-tetrahydroisoquinoline. 
The general procedure 1 using 1,2,3,4-tetrahydroisoquinoline (0.76 mL) 
gave N-(benzoyloxy)-1,2,3,4-tetrahydroisoquinoline as reported 
previously.[18] 1H NMR (400 MHz, CDCl3)  3.12 (t, 2H, J = 6.0 Hz), 3.55 
(br s, 2H), 4.43 (br s, 2H, H1’), 7.06 (d, 1H, J = 6.4 Hz), 7.12-7.23 (m, 3H), 
    
 
 
 
 
 
7.42 (t, 2H, J = 7.7 Hz), 7.55 (t, 1H, J = 7.4 Hz), 8.00 (d, 2H, J = 7.1 Hz); 
13C NMR (101 MHz, CDCl3)  26.7 (CH2), 53.4 (CH2), 58.1 (CH2), 126.3 
(CH), 126.8 (CH), 126.9 (CH), 128.4 (CH), 128.4 (2CH), 129.3 (C), 129.5 
(2CH), 132.3 (C), 132.9 (C), 133.1 (CH), 164.9 (C, C=O). 
General procedure 2 for the deprotolithiation-zincation-amination of 
benzothiophene. 
To a stirred mixture of benzothiophene (0.20 g, 1.5 mmol) and 
ZnCl2·TMEDA (0.39 g, 1.5 mmol) in THF (3 mL) at ‒20 °C was added 
dropwise a THF-hexane solution of LiTMP (1.5 mmol) to a stirred, cooled 
(0 °C) solution of 2,2,6,6-tetramethylpiperidine (0.28 mL, 1.7 mmol) in 
THF (3 mL) and stirring for 5 min) cooled at ‒20 °C. After 0.5 h at ‒20 °C, 
the solution was added dropwise to the N-benzoyloxy secondary amine 
(1.2 mmol) and anhydrous copper(II) acetate (14 mg, 75 μmol) in THF 
(3 mL) at ‒20 °C. The mixture was stirred overnight before addition of an 
aqueous saturated solution of Na2CO3 (5 mL) and extraction with Et2O (3 
x 20 mL). The combined organic layers were dried over MgSO4, filtered 
and concentrated under reduced pressure. The crude product was 
purified by chromatography over silica gel (the eluent is given in the 
product description). 
2-(Diallylamino)benzothiophene (1a). 
The general procedure 2 using N-(benzoyloxy)diallylamine (0.26 g) gave 
1a (eluent: hexanes-CH2Cl2 95:5; Rf = 0.42) in 52% yield (0.14 g) as a 
yellow oil: IR (ATR): 566, 704, 736, 794, 863, 923, 1016, 1065, 1184, 
1258, 1355, 1416, 1439, 1540, 1563, 1640, 2962 cm-1; 1H NMR (300 
MHz, CDCl3)  3.97 (dt, 4H, J = 5.6 and 1.5 Hz), 5.26 (dd, 2H, J = 8.9 
and 1.5 Hz), 5.33 (dd, 2H, J = 17.3 and 1.6 Hz), 5.92 (ddt, 2H, J = 17.0, 
10.1 and 5.6 Hz), 6.06 (s, 1H, H3), 7.06 (t, 1H, J = 7.6 Hz), 7.24 (t, 1H, J 
= 7.6 Hz), 7.43 (dd, 1H, J = 8.0 and 1.1 Hz), 7.59 (d, 1H, J = 7.9 Hz); 13C 
NMR (75 MHz, CDCl3)  54.9 (2CH2), 96.5 (CH), 117.4 (2CH2), 120.0 
(CH), 120.3 (CH), 121.2 (CH), 124.4 (CH), 131.8 (C), 133.0 (2CH), 141.4 
(C), 155.7 (C). HRMS (EI) m/z calcd for C14H15NS: 229.0925; found: 
229.0921. 2,2’-Bi(benzothiophene) (1’) was also isolated. This compound 
could be obtained in 25% yield by performing the same procedure 
without O-benzoyl hydroxylamine: white powder; mp 262 °C (lit.[54] 260-
261 °C); IR (ATR): 476, 557, 722, 736, 814, 937, 1013, 1067, 1177, 1250, 
1420, 1451, 1711, 1944, 2851, 2923, 3053 cm-1; 1H NMR (300 MHz, 
CDCl3)  7.30-7.39 (m, 4H), 7.52 (s, 2H), 7.74-7.84 (m, 4H); 
13C NMR (75 
MHz, CDCl3)  121.6 (CH), 122.3 (CH), 123.9 (CH), 124.9 (CH), 125.1 
(CH), 137.4 (C), 139.6 (C), 140.3 (C). 
2-(Dibutylamino)benzothiophene (1b). 
The general procedure 2 using N-(benzoyloxy)dibutylamine (0.30 g) gave 
1b (eluent: hexanes-Et3N 95:5; Rf = 0.67) in 63% yield (0.25 g) as a 
yellow oil: IR (ATR): 726, 756, 919, 1018, 1065, 1111, 1133, 1194, 1243, 
1279, 1311, 1369, 1440, 1539, 1562, 2861, 2928, 2955 cm-1; 1H NMR 
(300 MHz, CDCl3)  0.96 (t, 6H, J = 7.3 Hz, CH3), 1.38 (dq, 4H, J = 14.6 
and 7.0 Hz, CH2), 1.65 (quintuplet, 4H, J = 7.5 Hz, CH2), 3.28 (t, 4H, J = 
7.5 Hz, CH2), 5.88 (s, 1H, H3), 6.97 (t, 1H, J = 7.5 Hz), 7.18 (t, 1H, J = 
7.5 Hz), 7.36 (d, 1H, J = 7.9 Hz), 7.53 (d, 1H, J = 7.9 Hz); 13C NMR (75 
MHz, CDCl3)  14.0 (2CH3), 20.4 (2CH2), 29.5 (2CH2), 53.2 (2CH2), 94.9 
(CH), 119.6 (CH), 119.8 (CH), 121.3 (CH), 124.5 (CH), 131.6 (C), 141.9 
(C), 156.3 (C). HRMS (EI) m/z calcd for C16H23NS: 261.1551; found: 
261.1549. 
2-(Morpholino)benzothiophene (1c). 
The general procedure 2 using N-(benzoyloxy)morpholine (0.25 g) gave 
1c (eluent: hexanes-Et3N 98:2; Rf = 0.30) in 29% yield (76 mg) as a 
beige powder: mp 180 °C (lit.[10a] 180-181.5 °C); IR (ATR): 569, 592, 653, 
723, 744, 780, 868, 901, 1013, 1065, 1116, 1186, 1212, 1250, 1264, 
1303, 1375, 1437, 1455, 1527, 1557, 2850, 2958 cm-1; 1H NMR (300 
MHz, CDCl3)  3.24 (t, 4H, J = 4.9 Hz), 3.86 (t, 4H, J = 4.8 Hz), 6.23 (s, 
1H, H3), 7.10 (t, 1H, J = 7.6 Hz), 7.25 (t, 1H, J = 7.4 Hz), 7.48 (d, 1H, J = 
7.9 Hz), 7.61 (d, 1H, J = 7.9 Hz); 13C NMR (75 MHz, CDCl3)  51.1 
(2CH2), 66.4 (2CH2), 99.6 (CH), 121.2 (CH), 121.7 (CH), 121.8 (CH), 
124.7 (CH), 132.8 (C), 140.4 (C), 157.9 (C). These data are as reported 
previously.[10a]  
2-(Piperidino)benzothiophene (1d). 
The general procedure 2 using N-(benzoyloxy)piperidine (0.25 g) gave 
1d (eluent: hexanes-Et3N 98:2; Rf = 0.40) in 68% yield (0.18 g) as a white 
powder: mp 102 °C (lit.[55] 99-100 °C); IR (ATR): 479, 558, 581, 641, 721, 
734, 772, 812, 855, 1009, 1069, 1117, 1203, 1236, 1255, 1316, 1384, 
1439, 1532, 1559, 1717, 2935, 3055 cm-1; 1H NMR (300 MHz, CDCl3)  
1.61-1.67 (m, 2H), 1.73-1.80 (m, 4H), 3.28 (t, 4H, J = 5.5 Hz), 6.18 (s, 1H, 
H3), 7.08 (t, 1H, J = 7.5 Hz), 7.24 (t, 1H, J = 7.5 Hz), 7.46 (d, 1H, J = 7.6 
Hz), 7.61 (d, J = 7.9 Hz, 1H); 13C NMR (75 MHz, CDCl3)  24.0 (CH2), 
25.3 (2CH2), 52.1 (2CH2), 98.5 (CH), 120.7 (CH), 121.0 (CH), 121.6 (CH), 
124.5 (CH), 132.7 (C), 141.0 (C), 158.6 (C). Crystal data for 1d. 
C13H15NS, M = 217.32, triclinic, P -1, a = 6.0747(7), b = 12.9937(15), c = 
14.7777(18) Å, α = 74.742(4), β = 82.826(4), γ = 86.354(4) °, V = 
1115.9(2) Å3, Z = 4, d = 1.293 g cm-3, μ = 0.255 mm-1. A final refinement 
on F2 with 5071 unique intensities and 297 parameters converged at 
ωR(F2) = 0.0949 (R(F) = 0.0411) for 4457 observed reflections with I > 
2σ(I). CCDC 1896366. 
2-Chloro-5-(diallylamino)thiophene (2a). 
The general procedure 2, from 2-chlorothiophene (0.18 g) instead of 
thiophene, using N-(benzoyloxy)diallylamine (0.26 g) gave 2a (eluent: 
hexanes-Et3N 95:5; Rf = 0.50) in 49% yield (0.13 g) as a colorless oil of 
low stability (e.g. a solution in CDCl3 becomes dark after a few minutes): 
1H NMR (300 MHz, CDCl3)  3.77 (d, 1H, J = 5.8 Hz), 5.20 (dd, 2H, J = 
10.0 and 1.3 Hz), 5.22 (dd, 2H, J = 17.2 and 1.5 Hz), 5.71 (d, 1H, J = 4.0 
Hz), 5.83 (ddt, 2H, J = 16.0, 10.4 and 5.8 Hz), 6.53 (d, 1H, J = 4.0 Hz). 
Before the IR spectra and 13C NMR could be recorded, degradation to 
give allylated products was noticed and formation of 5,5’-dichloro-2,2’-
bithiophene (2a’) was identified by NMR: 1H NMR (300 MHz, CDCl3)  
6.82 (d, 2H, J = 3.9 Hz), 6.85 (d, 2H, J = 3.9 Hz); 13C NMR (75 MHz, 
CDCl3)  123.2 (2CH), 127.0 (2CH), 129.3 (2C), 135.2 (2C). These NMR 
data are similar to those reported previously.[56] Crystal data for 2a’. 
C8H4Cl2S2, M = 235.13, orthorhombic, P c c n, a = 7.3894(12), b = 
21.610(3), c = 5.7035(9) Å, V = 910.8(2) Å3, Z = 4, d = 1.715 g cm-3, μ = 
1.104 mm-1. A final refinement on F2 with 1041 unique intensities and 55 
parameters converged at ωR(F2) = 0.1336 (R(F) = 0.0682) for 904 
observed reflections with I > 2σ(I). CCDC 1896367. 
4-(Diallylamino)-1,5-naphthyridine (3a) by deprotometalation-
amination of 1,5-naphthyridine. 
To a stirred mixture of 1,5-naphthyridine (0.13 g, 1.0 mmol) in THF 
(3 mL) at room temperature was added dropwise a solution of 
TMPZnCl·LiCl (1.04 M THF solution; 1.1 mmol). After 2 h at this 
temperature, the mixture was treated dropwise by a solution of N-
(benzoyloxy)diallylamine (0.18 g, 0.8 mmol) and anhydrous copper(II) 
acetate (9 mg, 50 μmol) in THF (3 mL). It was stirred overnight before 
addition of an aqueous saturated solution of NH4Cl (4 mL) and extraction 
with AcOEt (3 x 10 mL). The combined organic layers were washed by 
aqueous saturated solutions of NaHCO3 (4 mL) and brine (4 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure to afford, 
    
 
 
 
 
 
after chromatography over silica gel (eluent: AcOEt; Rf = 0.50), 3a in 
64% yield (0.11 g) as a yellow oil: IR (ATR): 555, 610, 657, 712, 790, 823, 
919, 993, 1111, 1171, 1232, 1249, 1288, 1347, 1411, 1480, 1504, 1563, 
1639, 2910, 2980, 3075 cm-1; 1H NMR (300 MHz, CDCl3)  4.42 (dd, 4H, 
J = 4.3 and 2.8 Hz, H1’), 5.19-5.25 (m, 4H, H3’), 6.04 (ddt, 2H, J = 17.8, 
9.9 and 5.5 Hz, H2’), 6.69 (d, 1H, J = 5.5 Hz, H3), 7.50 (dd, 1H, J = 8.5 
and 4.0 Hz, H7), 8.23 (dd, 1H, J = 8.5 and 1.8 Hz, H8), 8.50 (d, 1H, J = 
5.5 Hz, H2), 8.73 (dd, 1H, J = 4.1 and 1.7 Hz, H6); 13C NMR (75 MHz, 
CDCl3)  54.7 (2CH2), 107.1 (CH), 117.4 (2CH2), 123.8 (CH), 134.0 
(2CH), 137.4 (CH), 137.9 (C), 145.3 (C), 146.0 (CH), 150.8 (CH), 152.5 
(C). HRMS (EI) m/z calcd for C14H15N3: 225.1266; found: 225.1268. 
4-(Diisopropylamino)-1,5-naphthyridine (3b) by deprotometalation-
amination of 1,5-naphthyridine. 
To a stirred mixture of 1,5-naphthyridine (0.13 g, 1.0 mmol) in THF 
(3 mL) at ‒40 °C was added dropwise a solution of TMPMgCl·LiCl 
(1.07 M THF solution; 1.1 mmol). After 1 h at this temperature, the 
mixture was treated dropwise by a solution of N-
(benzoyloxy)diisopropylamine (0.18 g, 0.8 mmol) and anhydrous 
copper(II) acetate (9 mg, 50 μmol) in THF (3 mL). It was slowly warmed 
to room temperature and stirred overnight before addition of an aqueous 
saturated solution of NH4Cl (4 mL) and extraction with AcOEt (3 x 10 mL). 
The combined organic layers were washed by aqueous saturated 
solutions of NaHCO3 (4 mL) and brine (4 mL), dried over MgSO4, filtered 
and concentrated under reduced pressure to afford, after 
chromatography over silica gel (eluent: AcOEt; Rf = 0.27), 3b in 52% 
yield (95 mg) as a yellow oil: 1H NMR (400 MHz, CDCl3)  1.42 (d, 12H, J 
= 6.8 Hz, CH3), 4.57 (septuplet, 2H, J = 6.8 Hz), 6.95 (d, 1H, J = 5.6 Hz, 
H3), 7.46 (dd, 1H, J = 8.5 and 4.0 Hz, H7), 8.20 (dd, 1H, J = 8.5 and 1.7 
Hz, H8), 8.46 (d, 1H, J = 5.6 Hz, H2), 8.71 (dd, 1H, J = 4.0 and 1.7 Hz, 
H6); 13C NMR (101 MHz, CDCl3)  21.9 (4CH3), 50.5 (2CH), 110.2 (CH), 
123.6 (CH), 137.2 (CH), 139.7 (C), 145.6 (CH), 145.8 (C), 149.8 (CH), 
152.9 (C). Note that 3b is contaminated with impurities. 
4-Iodo-1,5-naphthyridine (3-I). 
To a stirred mixture of 1,5-naphthyridine (0.26 g, 2.0 mmol) in THF 
(4 mL) at room temperature was added dropwise a solution of 
TMPZnCl·LiCl[22] (1.04 M THF solution; 2.4 mmol). After 2 h at room 
temperature, a solution of iodine (0.76 g, 3.0 mmol) in THF (3 mL) was 
added. The resulting mixture was stirred overnight before addition of an 
aqueous saturated solution of Na2S2O3 (5 mL) and extraction with AcOEt 
(3 x 10 mL). The combined organic layers were washed with brine (5 mL), 
dried over Na2SO4, filtered and concentrated under reduced pressure. 
The crude product was purified by chromatography over silica gel 
(eluent: hexanes-AcOEt 60:40) to afford 3-I in 72% yield (0.37 g) as a 
whitish powder: mp 91-93 °C; 1H NMR (300 MHz, CDCl3)  7.70 (dd, 1H, 
J = 8.5 and 4.2 Hz, H7), 8.28 (d, 1H, J = 4.5 Hz), 8.37 (dd, 1H, J = 8.4 
and 1.6 Hz, H8), 8.53 (d, 1H, J = 4.5 Hz), 9.06 (dd, 1H, J = 4.2 and 1.6 
Hz, H6); 13C NMR (75 MHz, CDCl3)  116.4 (C, C-I), 125.5 (CH), 135.4 
(CH), 138.4 (CH), 143.9 (C), 144.0 (C), 150.8 (CH), 152.2 (CH). These 
data are similar to those described previously.[22] Using procedure 3 led 
to both 3-I (34% yield) and 4,8-diiodo-1,5-naphthyridine 3’-I. The latter 
was isolated in 6% yield as a white powder: mp > 260 °C; IR (ATR): 491, 
590, 630, 683, 851, 1031, 1079, 1167, 1210, 1257, 1325, 1358, 1376, 
1398, 1459, 1578, 1695, 1957, 2851, 2921 cm-1; 1H NMR (300 MHz, 
CDCl3)  8.32 (d, 2H, J = 4.5 Hz), 8.58 (d, 2H, J = 4.5 Hz); 
13C NMR (75 
MHz, CDCl3)  116.6 (2C, C4 and C8), 136.4 (2CH, C3 and C7), 143.6 
(2C), 151.5 (2CH, C2 and C6). 
4-Morpholino-1,5-naphthyridine (3c). 
A degassed sealed tube containing 4-iodo-1,5-naphthyridine (3-I; 96 mg, 
0.375 mmol) and morpholine (0.195 mL, 2.25 mmol) in isopropanol 
(1 mL) was heated at 110 °C for 72 h. The cooled residue was poured 
onto brine and extracted with AcOEt (3 x 10 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated under reduced 
pressure. The crude product was purified by chromatography over silica 
gel (eluent: AcOEt; Rf = 0.30) to afford 3c in 70% yield (57 mg) as a 
white powder: mp 116-118 °C; IR (ATR): 1026, 1111, 1249, 1265, 1305, 
1372, 1414, 1477, 1503, 1566, 1604, 2864, 2966, 3205, 3350 cm-1; 1H 
NMR (300 MHz, CDCl3)  3.68-3.71 (m, 4H, 2CH2), 3.97-4.01 (m, 4H, 
2CH2), 6.84 (d, 1H, J = 5.1 Hz, H3), 7.55 (dd, 1H, J = 8.5 and 4.1 Hz, H7), 
8.30 (dd, 1H, J = 8.5 and 1.8 Hz, H8), 8.68 (d, 1H, J = 5.1 Hz, H2), 8.81 
(dd, 1H, J = 4.1 and 1.7 Hz, H6); 13C NMR (75 MHz, CDCl3)  51.1 
(2CH2), 66.9 (2CH2), 109.0 (CH), 124.0 (CH), 138.0 (CH), 138.6 (C), 
145.1 (C), 147.4 (CH), 151.5 (CH), 154.9 (C). HRMS (EI) m/z calcd for 
C12H13N3O: 215.1059; found: 215.1055. 
General procedure 3 for the preparation of 2-thienylzinc chloride or 
2-benzothienylzinc chloride (insertion method A),[28] and 
subsequent amination.[17] 
A dry and argon flushed Schlenk flask equipped with a magnetic stirring 
bar and a septum was charged with magnesium turnings (0.30 g, 
12.5 mmol), LiCl (0.32 g, 7.5 mmol) and THF (15 mL). The aromatic 
bromide (5.0 mmol) was added dropwise. If necessary, the Schlenk flask 
was placed in a water bath for cooling during the initial heat evolution of 
the insertion reaction. The progress of the insertion reaction was 
monitored by GC-analysis of reaction aliquots quenched with an aqueous 
saturated NH4Cl solution and/or iodine. Upon completion of the insertion, 
ZnCl2 (1.0 M) solution (6.0 mL, 6.0 mmol) was added dropwise. The 
organozinc reagent was titrated using iodine solution (1.0 M in THF) 
before use in the amination reaction. A dry and argon flushed flask 
equipped with a magnetic stirring bar and a septum was charged with the 
N-benzoyloxy secondary amine (0.50 mmol) and THF (2 mL). To the 
mixture CoCl2·2LiCl (50 μmol) was added as a 1.0 M solution in THF. 
Then, the prepared organozinc chloride (0.55 mmol) in THF was added 
dropwise. The solution was stirred for 2 h at room temperature and the 
reaction progress checked by thin layer chromatography. Upon 
completion of starting material (approximately less than 2 h), the reaction 
was quenched with saturated aqueous NH4Cl solution (1 mL) and the 
product was extracted with AcOEt (3 x 15 mL). The combined organic 
layers were washed with saturated aqueous NaHCO3 solution (15 mL) 
and brine (15 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude product was purified by chromatography 
over silica gel (the eluent is given in the product description). 
2-(Morpholino)benzothiophene (1c). 
The general procedure 3 using 2-bromobenzothiophene (1.1 g) and N-
(benzoyloxy)morpholine (0.10 g) gave 1c (eluent: hexanes-AcOEt 90:10) 
in 96% yield (0.10 g) as a white powder: IR (ATR): 900, 1012, 1090, 
1263, 1298, 1374, 1435, 1526, 1666, 2838 cm-1; 1H NMR (400 MHz, 
CDCl3)  3.24 (t, 4H, J = 4.9 Hz), 3.86 (t, 4H, J = 4.8 Hz), 6.23 (s, 1H, H3), 
7.10 (t, 1H, J = 7.6 Hz), 7.25 (t, 1H, J = 7.4 Hz), 7.48 (d, 1H, J = 7.9 Hz), 
7.61 (d, 1H, J = 7.9 Hz); 13C NMR (101 MHz, CDCl3)  51.1 (2CH2), 66.4 
(2CH2), 99.6 (CH), 121.2 (CH), 121.7 (CH), 121.8 (CH), 124.7 (CH), 
132.8 (C), 140.4 (C), 157.9 (C). These data are as reported 
previously.[10a] MS (EI, 70 eV) m/z (%) 69 (12), 89 (44), 121 (17), 133 
(14), 134 (72), 147 (50), 160 (100), 161 (99), 219 (19); HRMS (EI) m/z 
calcd for C12H13NOS: 219.0718; found: 219.0711. 
2-Morpholinothiophene (2c). 
    
 
 
 
 
 
The general procedure 3 using 2-bromothiophene (0.82 g) and N-
(benzoyloxy)morpholine (0.10 g) gave 2c (eluent: hexanes-AcOEt 90:10) 
in 80% yield (68 mg) as a brown oil: IR (ATR): 928, 1028, 1090, 1208, 
1269, 1293, 1374, 1443, 1466, 1528, 2853 cm-1; 1H NMR (400 MHz, 
CDCl3)  3.12-3.14 (m, 4H), 3.83-3.85 (m, 4H), 6.16 (dd, 1H, J = 3.7 and 
1.4 Hz, H3), 6.64 (dd, 1H, J = 5.2 and 1.1 Hz, H5), 6.80 (dd, 1H, J = 5.4 
and 3.8 Hz, H4); 13C NMR (101 MHz, CDCl3)  52.2 (2CH2), 66.7 (2CH2), 
105.9 (CH), 113.1 (CH), 126.4 (CH), 159.5 (C). These data are as 
reported previously.[57] MS (EI, 70 eV) m/z (%) 110 (33), 111 (61), 154 
(11), 169 (100); HRMS (EI) m/z calcd for C8H11NOS: 169.0561; found: 
169.0554. 
2-[Di(2-methoxyethyl)amino]thiophene (2e). 
The general procedure 3 using 2-bromothiophene (0.82 g) and N-
(benzoyloxy)di(2-methoxyethyl)amine (0.13 g) gave 2e (eluent: hexanes-
AcOEt 90:10) in 52% yield (56 mg) as a brown oil: IR (ATR): 1012, 1100, 
1185, 1360, 1446, 1533, 1639, 2922 cm-1; 1H NMR (400 MHz, CDCl3)  
3.35 (s, 6H, OMe), 3.49 (td, 4H, J = 5.8 and 0.7 Hz, CH2), 3.57 (td, 4H, J 
= 5.8 and 0.85 Hz, CH2), 5.90 (dd, 1H, J = 3.7 and 1.3 Hz, H3), 6.42 (dd, 
1H, J = 5.4 and 1.4 Hz, H5), 6.75 (dd, 1H, J = 5.5 and 3.7 Hz, H4); 13C 
NMR (101 MHz, CDCl3)  54.3 (2CH2), 59.1 (2CH3), 70.2 (2CH2), 102.3 
(CH), 109.3 (CH), 126.7 (CH), 157.3 (C); MS (EI, 70 eV) m/z (%) 112 
(10), 138 (12), 170 (100), 215 (31); HRMS (EI) m/z calcd for 
C10H17NO2S: 215.0980; found: 215.0974. 
2-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)]thiophene (2f). 
The general procedure 3 using 2-bromothiophene (0.82 g) and N-
(benzoyloxy)-1,4-dioxa-8-azaspiro[4.5]decane (0.13 g) gave 2f (eluent: 
hexanes-AcOEt 90:10) in 78% yield (88 mg) as a brown oil: IR (ATR): 
1035, 1100, 1141, 1226, 1363, 1454, 1527, 2955 cm-1; 1H NMR (400 
MHz, CDCl3)  1.85 (t, 4H, J = 5.9 Hz), 3.28 (t, 4H, J = 5.8 Hz), 3.98 (s, 
4H, OCH2CH2O), 6.12 (dd, 1H, J = 3.8 and 1.4 Hz, H3), 6.59 (dd, 1H, J = 
5.5 and 1.4 Hz, H5), 6.76 (dd, 1H, J = 5.5 and 3.8 Hz, H4); 13C NMR (101 
MHz, CDCl3)  34.2 (2CH2), 50.5 (2CH2), 64.5 (2CH2), 106.1 (CH), 106.8 
(C, C5’), 112.5 (CH), 126.2 (CH), 159.1 (C); MS (EI, 70 eV) m/z (%) 110 
(25), 111 (67), 138 (21), 164 (13), 180 (12), 225 (100), 226 (11); HRMS 
(EI) m/z calcd for C11H15NO2S: 225.0823; found: 225.0816. 
General procedure 4 for the preparation of 2-thiazolylzinc chloride 
or 2-benzothiazolylzinc chloride (exchange method B),[29] and 
subsequent amination.[17] 
A dry and argon flushed 10 mL flask, equipped with a magnetic stirrer 
and a septum, was charged with iPrMgCl·LiCl (1.0 mL, 1.05 mmol, 
1.05 M in THF). The neat aryl bromide (1.0 mmol) was added at room 
temperature. The reaction mixture was stirred for 0.5 h, and the 
completion of the Br/Mg exchange was checked by GC-analysis using 
tetradecane as internal standard. Upon completion of the exchange, 
ZnCl2 (1.0 M) solution (1.2 mL, 1.2 mmol) was added dropwise. The 
organozinc reagent was titrated using iodine solution (1.0 M in THF) 
before use in the amination reaction. A dry and argon flushed flask 
equipped with a magnetic stirring bar and a septum was charged with the 
N-benzoyloxy secondary amine (0.50 mmol) and THF (2 mL). To the 
mixture CoCl2·2LiCl (50 μmol) was added as a 1.0 M solution in THF. 
Then, the prepared organozinc chloride (0.55 mmol) in THF was added 
dropwise. The solution was stirred for 2 h at room temperature and the 
reaction progress checked by thin layer chromatography. Upon 
completion of starting material (approximately less than 2 h), the reaction 
was quenched with saturated aqueous NH4Cl solution (1 mL) and the 
product was extracted with AcOEt (3 x 15 mL). The combined organic 
layers were washed with saturated aqueous NaHCO3 solution (15 mL) 
and brine (15 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude product was purified by chromatography 
over silica gel (the eluent is given in the product description). 
2-Morpholinothiazole (4c). 
The general procedure 4 using 2-bromothiazole (0.16 g) and N-
(benzoyloxy)morpholine (0.10 g) gave 4c (eluent: hexanes-AcOEt 90:10) 
in 76% yield (65 mg) as a brown oil: IR (ATR): 905, 1034, 1140, 1229, 
1270, 1373, 1447, 1511, 2852 cm-1; 1H NMR (400 MHz, CDCl3)  3.46-
3.48 (m, 4H), 3.81-3.83 (m, 4H), 6.60 (d, 1H, J = 3.6 Hz), 7.22 (d, 1H, J = 
3.7 Hz); 13C NMR (101 MHz, CDCl3)  48.9 (2CH2), 66.1 (2CH2), 108.1 
(CH), 139.8 (CH), 172.6 (C). These data are as reported previously.[58] 
MS (EI, 70 eV) m/z (%) 58 (18), 85 (49), 86 (15), 99 (14), 100 (33), 101 
(11), 111 (19), 112 (34), 113 (88), 125 (32), 126 (13), 139 (42), 151 (12), 
155 (20), 168 (22), 169 (23), 170 (100); HRMS (EI) m/z calcd for 
C7H10N2OS: 170.0514; found: 170.0506. 
2-[Di(2-methoxyethyl)amino]benzothiazole (5e). 
The general procedure 4 using 2-bromobenzothiazole (0.21 g) and N-
(benzoyloxy)di(2-methoxyethyl)amine (0.13 g) gave 5e (eluent: hexanes-
AcOEt 90:10) in 56% yield (74 mg) as a yellow oil: IR (ATR): 749, 1111, 
1309, 1442, 1549, 1560, 1702, 2875 cm-1; 1H NMR (400 MHz, CDCl3)  
3.40 (s, 6H, OMe), 3.70 (t, 4H, J = 5.5 Hz), 3.82 (t, 4H, J = 5.5 Hz), 7.04 
(ddd, 1H, J = 7.8, 7.3 and 1.2 Hz), 7.27 (ddd, 1H, J = 8.6, 7.4 and 1.3 Hz), 
7.53 (ddd, 1H, J = 8.1, 1.0 and 0.4 Hz), 7.59-7.61 (ddd, 1H, J = 7.8, 1.2 
and 0.4 Hz); 13C NMR (101 MHz, CDCl3)  52.3 (2CH2), 59.3 (2CH3), 
70.8 (2CH2), 119.1 (CH), 120.9 (CH), 121.3 (CH), 126.2 (CH), 131.1 (C), 
153.4 (C), 168.2 (C). These data are as reported previously.[59] MS (EI, 
70 eV) m/z (%) 136 (16), 150 (21), 163 (100), 178 (25), 191 (43), 208 
(36), 221 (20); HRMS (EI) m/z calcd for C13H18N2O2S: 266.1089; found: 
266.1079. 
2-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)]benzothiazole (5f). 
The general procedure 4 using 2-bromobenzothiazole (0.21 g) and N-
(benzoyloxy)-1,4-dioxa-8-azaspiro[4.5]decane (0.13 g) gave 5f (eluent: 
hexanes-AcOEt 90:10) in 88% yield (0.12 g) as a yellow oil: IR (ATR): 
922, 1099, 1291, 1446, 1543, 1595, 2925 cm-1; 1H NMR (400 MHz, 
CDCl3)  1.83 (t, 4H, J = 5.9 Hz), 3.75 (dd, 4H, J = 6.6 and 5.1 Hz), 4.02 
(s, 4H, OCH2CH2O), 7.06 (td, 1H, J = 7.6 and 1.1 Hz), 7.28 (ddd, 1H, J = 
8.5, 7.4 and 1.3 Hz), 7.54 (dd, 1H, J = 8.1 and 0.6 Hz), 7.58-7.60 (m, 
1H); 13C NMR (101 MHz, CDCl3)  34.7 (2CH2), 47.1 (2CH2), 64.8 (2CH2), 
107.2 (C, C5’), 119.3 (CH), 121.0 (CH), 121.7 (CH), 126.3 (CH), 131.3 
(C), 153.2 (C), 168.6 (C). These data are as reported previously.[60] MS 
(EI, 70 eV) m/z (%) 99 (20), 108 (14), 134 (12), 135 (46), 136 (12), 149 
(59), 161 (13), 162 (13), 163 (77), 175 (89), 176 (39), 177 (25), 189 (12), 
203 (12), 207 (16), 276 (100); HRMS (EI) m/z calcd for C14H16N2O2S: 
276.0932; found: 276.0922. 
2-(1-Azepanyl)benzothiazole (5g). 
The general procedure 4 using 2-bromobenzothiazole (0.21 g) and N-
(benzoyloxy)azepane (0.11 g) gave 5g (eluent: hexanes-AcOEt 90:10) in 
89% yield (0.10 g) as a yellow oil: IR (ATR): 748, 1249, 1299, 1359, 1441, 
1560, 2923 cm-1; 1H NMR (400 MHz, CDCl3)  1.61-1.64 (m, 4H), 1.85-
1.91 (m, 4H), 3.69 (t, 4H, J = 6.0 Hz), 7.03 (td, 1H, J = 7.6 and 1.1 Hz), 
7.28 (ddd, 1H, J = 8.2, 7.4 and 1.3 Hz), 7.55 (ddd, 1H, J = 8.0, 1.0 and 
0.4 Hz), 7.59 (ddd, 1H, J = 7.8, 1.2 and 0.4 Hz)); 13C NMR (101 MHz, 
CDCl3)  27.9 (2CH2), 28.2 (2CH2), 51.1 (2CH2), 118.7 (CH), 120.7 (CH), 
120.9 (CH), 126.2 (CH), 130.9 (C), 153.7 (C), 168.5 (C). These data are 
as reported previously.[61] MS (EI, 70 eV) m/z (%) 98 (11), 135 (17), 136 
    
 
 
 
 
 
(31), 149 (38), 150 (49), 162 (23), 163 (46), 175 (37), 177 (14), 189 (65), 
199 (23), 203 (18), 217 (27), 232 (100), 233 (14); HRMS (EI) m/z calcd 
for C13H16N2S: 232.1034; found: 232.1030. 
General procedure 5 for the preparation of 5-(2-thienyl)-2-thienylzinc 
chloride or 2-(thieno[3,2-b]thienyl)zinc chloride 
(deprotometalation)[31] and subsequent amination.[17] 
A dry and argon flushed Schlenk flask, equipped with a magnetic stirrer 
and a septum, was charged with the starting bithiophene or 
thienothiophene (0.50 mmol) in THF (approximately 1.0 M solution) at 
room temperature. A solution of TMPMgCl·LiCl (0.55 mmol) in THF was 
added dropwise and the reaction mixture stirred for 1 h (the completion of 
the reaction was checked by GC analysis of reaction aliquots quenched 
with a solution of I2 in THF). Upon completion of the deprotonation, ZnCl2 
(1.0 M) solution (0.60 ml, 0.60 mmol) was added dropwise. The 
organozinc reagent was titrated using iodine solution (1.0 M in THF) 
before use in the amination reaction. A dry and argon flushed flask 
equipped with a magnetic stirring bar and a septum was charged with the 
N-benzoyloxy secondary amine (0.50 mmol) and THF (about 2 mL). 
CoCl2·2LiCl (50 μmol; 1.0 M solution in THF) and TMEDA (15 μL, 
0.10 mmol) were added to the mixture. Then, the prepared organozinc 
chloride (0.55 mmol) in THF was added dropwise. The solution was 
stirred for 2 h at room temperature and the reaction progress checked by 
thin layer chromatography. Upon completion of starting material 
(approximately less than 2 h), the reaction was quenched with saturated 
aqueous NH4Cl solution (1 mL) and the product was extracted with 
AcOEt (3 x 15 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 solution (15 mL) and brine (15 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure. The 
crude product was purified by chromatography over silica gel (the eluent 
is given in the product description). 
5-Morpholino-2,2’-bithiophene (6c). 
The general procedure 5, but without TMEDA, using 2,2’-bithiophene 
(83 mg) and N-(benzoyloxy)morpholine (0.10 g) gave 6c (eluent: 
hexanes-AcOEt 90:10) in 72% yield (90 mg) as a yellow powder: IR 
(ATR): 899, 1115, 1296, 1450, 1535, 1594, 2925 cm-1; 1H NMR (400 
MHz, CDCl3)  3.15-3.16 (m, 4H), 3.85-3.87 (m, 4H), 6.08 (d, 1H, J = 3.9 
Hz), 6.88 (d, 1H, J = 3.7 Hz), 6.96 (dd, 1H, J = 5.1 and 3.6 Hz, H4’), 6.99 
(dd, 1H, J = 3.6 and 1.2 Hz, H3’), 7.11 (dd, 1H, J = 5.0 and 1.3 Hz, H5’); 
13C NMR (101 MHz, CDCl3)  51.6 (2CH2), 66.6 (2CH2), 106.0 (CH), 
122.1 (CH), 123.1 (CH), 123.2 (CH), 124.6 (C), 127.9 (CH), 138.5 (C), 
158.5 (C). These data are as reported previously.[62] MS (EI, 70 eV) m/z 
(%) 121 (16), 179 (12), 191 (38), 193 (77), 251 (100); HRMS (EI) m/z 
calcd for C12H13NOS2: 251.0439; found: 251.0435. 
2-(Morpholino)thieno[3,2-b]thiophene (7c). 
The general procedure 5 using thieno[3,2-b]thiophene (70 mg) and N-
(benzoyloxy)morpholine (0.10 g) gave 7c (eluent: hexanes-CH2Cl2 80:20) 
in 92% yield (0.10 g) as a white powder: IR (ATR): 925, 1100, 1217, 
1261, 1374, 1442, 1509, 2831 cm-1; 1H NMR (400 MHz, CDCl3)  3.16-
3.18 (m, 4H), 3.85-3.88 (m, 4H), 6.37 (s, 1H), 7.10 (d, 1H, J = 5.2 Hz), 
7.12 (d, 1H, J = 5.2 Hz); 13C NMR (101 MHz, CDCl3)  52.1 (2CH2), 66.4 
(2CH2), 99.5 (CH), 119.6 (CH), 122.8 (CH), 128.6 (C), 138.1 (C), 160.1 
(C). MS (EI, 70 eV) m/z (%) 69 (10), 122 (12), 139 (10), 140 (46), 153 
(23), 166 (47), 167 (99), 207 (13), 223 (16), 225 (100); HRMS (EI) m/z 
calcd for C10H11NOS2: 225.0282; found: 225.0276. 
2-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)]thieno[3,2-b]thiophene (7f). 
The general procedure 5 using thieno[3,2-b]thiophene (70 mg) and N-
(benzoyloxy)-1,4-dioxa-8-azaspiro[4.5]decane (0.13 g) gave 7f (eluent: 
hexanes-CH2Cl2 80:20) in 85% yield (0.12 g) as a green powder: IR 
(ATR): 1066, 1115, 1297, 1442, 1520, 2926 cm-1; 1H NMR (400 MHz, 
CDCl3)  1.87 (t, 4H, J = 5.9 Hz), 3.32 (t, 4H, J = 5.8 Hz), 4.00 (s, 4H, 
OCH2CH2O), 6.32 (s, 1H), 7.08 (s, 2H); 
13C NMR (101 MHz, CDCl3)  
34.2 (2CH2), 50.4 (2CH2), 64.6 (2CH2), 98.9 (CH), 106.8 (C, C5’), 119.6 
(CH), 121.9 (CH), 128.2 (C), 138.4 (C), 160.7 (C); MS (EI, 70 eV) m/z 
(%) 140 (22), 166 (20), 167 (100), 207 (38), 209 (21), 225 (48), 281 (34); 
HRMS (EI) m/z calcd for C13H15NO2S2: 281.0544; found: 281.0537. 
2-[2-(1,2,3,4-tetrahydroisoquinolyl)]thieno[3,2-b]thiophene (7h). 
The general procedure 5 using thieno[3,2-b]thiophene (70 mg) and N-
(benzoyloxy)-1,2,3,4-tetrahydroisoquinoline (0.13 g) gave 7h (eluent: 
hexanes-CH2Cl2 80:20) in 88% yield (0.12 g) as a green powder: IR 
(ATR): 928, 1196, 1380, 1454, 1519, 2831 cm-1; 1H NMR (400 MHz, 
CDCl3)  3.04 (t, 2H, J = 6.0 Hz), 3.54 (t, 2H, J = 6.0 Hz), 4.41 (s, 2H, 
H1’), 6.40 (s, 1H), 7.08 (d, 1H, J = 5.2 Hz), 7.11 (d, 1H, J = 5.2 Hz), 7.14-
7.23 (m, 4H); 13C NMR (101 MHz, CDCl3)  28.8 (CH2), 49.6 (CH2), 53.1 
(CH2), 97.9 (CH), 119.6 (CH), 121.8 (CH), 126.3 (CH), 126.5 (CH), 126.7 
(CH), 127.6 (C), 128.9 (CH), 133.1 (C), 134.0 (C), 138.6 (C), 160.1 (C); 
MS (EI, 70 eV) m/z (%) 73 (13), 77 (12), 78 (15), 88 (11), 91 (16), 103 
(16), 104 (58), 115 (24), 117 (49), 139 (17), 166 (68), 270 (30), 271 (100), 
272 (21), 273 (13), 277 (22); HRMS (EI) m/z calcd for C15H13NS2: 
271.0489; found: 271.0498. This compound is quite instable in CDCl3. 
General procedure 6 for the preparation of 2-thiooxo-4-(1,3-
dithiolyl)zinc chloride (deprotometalation),[32] and subsequent 
amination.[17] 
A dry and argon flushed Schlenk flask was charged with a solution of 1,3-
dithiole-2-thione (0.50 mmol) in anhydrous THF (approximately 0.5 M 
solution). A solution of TMPMgCl·LiCl (0.55 mmol) in THF was added 
dropwise at –78 °C and the mixture was stirred at this temperature for 
0.5 h. The completion of the reaction was checked by GC analysis of 
reaction aliquots quenched with I2. Upon completion of the deprotonation, 
a ZnCl2 (0.60 mL, 0.60 mmol) solution (1.0 M in THF) was added 
dropwise. The organozinc reagent was titrated using iodine solution 
(1.0 M in THF) before use in the amination reaction. A dry and argon 
flushed flask equipped with a magnetic stirring bar and a septum was 
charged with the N-benzoyloxy secondary amine (0.50 mmol) and THF 
(about 2 mL). CoCl2·2LiCl (50 μmol; 1.0 M solution in THF) and TMEDA 
(15 μL, 0.10 mmol) were added to the mixture. Then, the prepared 
organozinc chloride (0.55 mmol) in THF was added dropwise. The 
solution was stirred for 2 h at room temperature and the reaction 
progress checked by thin layer chromatography. Upon completion of 
starting material (approximately less than 2 h), the reaction was 
quenched with saturated aqueous NH4Cl solution (1 mL) and the product 
was extracted with AcOEt (3 x 15 mL). The combined organic layers 
were washed with saturated aqueous NaHCO3 solution (15 mL) and 
brine (15 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude product was purified by chromatography 
over silica gel (the eluent is given in the product description). 
4-Morpholino-1,3-dithiole-2-thione (8c). 
The general procedure 6 using N-(benzoyloxy)morpholine (0.10 g) gave 
8c (eluent: hexanes-AcOEt 90:10) in 73% yield (80 mg) as a yellow 
powder: IR (ATR): 867, 1000, 1111, 1214, 1273, 1375, 1442, 1531, 2834 
cm-1; 1H NMR (400 MHz, CDCl3)  3.07-3.10 (m, 4H), 3.79-3.81 (m, 4H), 
5.63 (s, 1H, H5); 13C NMR (101 MHz, CDCl3)  51.0 (2CH2), 66.1 (2CH2), 
98.8 (CH, C5), 155.2 (C, C4), 207.9 (C, C=S); MS (EI, 70 eV) m/z (%) 48 
    
 
 
 
 
 
(27), 49 (100), 50 (12), 52 (25), 60 (15), 73 (11), 75 (14), 84 (30), 115 
(11), 143 (31); HRMS (EI) m/z calcd for C7H9NOS3: 219.9846; found: 
219.9902. 
4-[Di(2-methoxyethyl)amino]-1,3-dithiole-2-thione (8e). 
The general procedure 6 using N-(benzoyloxy)di(2-methoxyethyl)amine 
(0.13 g) gave 8e (eluent: hexanes-AcOEt 90:10) in 95% yield (0.13 g) as 
a red oil: IR (ATR): 942, 1054, 1099, 1363, 1455, 1534, 2978 cm-1; 1H 
NMR (400 MHz, CDCl3)  3.35 (s, 6H, OMe), 3.43 (t, 4H, J = 6.0 Hz), 
3.54 (t, 4H, J = 6.0 Hz), 5.39 (s, 1H); 13C NMR (101 MHz, CDCl3)  53.9 
(2CH2), 59.2 (2CH3), 70.1 (2CH2), 93.1 (CH, C5), 153.6 (C, C4), 206.7 (C, 
C=S); MS (EI, 70 eV) m/z (%) 76 (100), 78 (10), 207 (13), 225 (11); 
HRMS (EI) m/z calcd for C9H15NO2S3: 265.0265; found: 265.0264. 
4-[8-(1,4-Dioxa-8-azaspiro[4.5]decyl)]-1,3-dithiole-2-thione (8f). 
The general procedure 6 using N-(benzoyloxy)-1,4-dioxa-8-
azaspiro[4.5]decane (0.13 g) gave 8f (eluent: hexanes-AcOEt 90:10) in 
98% yield (0.13 g) as a yellow powder: IR (ATR): 920, 1022, 1099, 1145, 
1365, 1455, 1532, 2950 cm-1; 1H NMR (400 MHz, CDCl3)  1.78 (t, 4H, J 
= 5.9 Hz, 2CH2), 3.20 (t, 4H, J = 5.9 Hz, 2CH2), 3.94 (s, 4H, OCH2CH2O), 
5.55 (s, 1H, H5); 13C NMR (101 MHz, CDCl3)  33.9 (2CH2), 49.5 (2CH2), 
64.6 (2CH2), 98.5 (CH, C5), 106.0 (C, C5’), 155.1 (C, C4), 208.2 (C, 
C=S); MS (EI, 70 eV) m/z (%) 43 (100), 45 (14), 61 (19), 70 (14), 98 (13), 
275 (50); HRMS (EI) m/z calcd for C10H13NO2S3: 275.0108; found: 
275.0100. 
4-[2-(1,2,3,4-tetrahydroisoquinolyl)]-1,3-dithiole-2-thione (8h). 
The general procedure 6 using N-(benzoyloxy)-1,2,3,4-
tetrahydroisoquinoline (0.13 g) gave 8h (eluent: hexanes-AcOEt 90:10) in 
96% yield (0.13 g) as a yellow powder: IR (ATR): 842, 1038, 1179, 1381, 
1448, 1532, 2921 cm-1; 1H NMR (400 MHz, CDCl3)  2.98 (t, 2H, J = 5.5 
Hz), 3.46 (t, 2H, J = 6.0 Hz), 4.33 (s, 2H, H1’), 5.57 (s, 1H, H5), 7.11 (dd, 
1H, J = 5.2 and 3.6 Hz), 7.16 (dd, 1H, J = 5.3 and 3.8 Hz), 7.20-7.24 (m, 
2H); 13C NMR (101 MHz, CDCl3)  28.6 (CH2), 49.1 (CH2), 52.0 (CH2), 
96.3 (CH, C5), 126.4 (CH), 126.7 (CH), 127.2 (CH), 128.9 (CH), 131.9 
(C), 133.5 (C), 154.3 (C, C4), 207.5 (C, C=S); MS (EI, 70 eV) m/z (%) 42 
(42), 75 (11), 91 (16), 103 (12), 104 (15), 115 (24), 117 (81), 118 (18), 
132 (14), 156 (21), 188 (57), 189 (15), 265 (100), 267 (14); HRMS (EI) 
m/z calcd for C12H11NS3: 265.0054; found: 265.0048. 
Methyl 3-(phenylamino)-2-thiophenecarboxylate (9a). 
To iodobenzene (0.11 mL, 1.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 3-amino-2-
thiophenecarboxylate (0.16 g, 1.0 mmol) and K2CO3 (0.28 g, 2.0 mmol). 
The mixture was degassed and heated at 140 °C under argon for 24 h. 
During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was added 
after 2, 4, 6 and 8 h of heating. After cooling to room temperature, the 
mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3x10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (eluent: hexanes-AcOEt 
95:5; Rf = 0.525) afforded 5a in 79% yield (0.18 g) as a yellow powder: 
mp 68 °C (lit.[35a] 66-67 °C); IR (ATR): 692, 754, 772, 1090, 1226, 1254, 
1394, 1418, 1435, 1566, 1593, 1667, 2948, 3309 cm-1; 1H NMR (300 
MHz, CDCl3)  3.88 (s, 3H, OMe), 7.06 (t, 1H, J = 7.4 Hz, H4’), 7.10 (d, 
1H, J = 5.5 Hz, H4), 7.18 (d, 2H, J = 7.7 Hz, H2’ and H6’), 7.33 (t, 2H, J = 
7.7 Hz, H3’ and H5’), 7.35 (d, 1H, J = 5.3 Hz, H5), 8.80 (br s, 1H, NH); 
13C NMR (75 MHz, CDCl3)  51.5 (CH3), 103.0 (C, C2), 118.0 (CH), 
120.3 (2CH, C2’ and C6’), 123.1 (CH), 129.4 (2CH, C3’ and C5’), 131.8 
(CH, C4), 141.5 (C, C1’), 151.5 (C, C3), 165.2 (C, C=O). These data are 
similar to those described previously.[35a] 
General procedure 7 for the bis-N-arylation of methyl 3-amino-2-
thiophenecarboxylate using the same iodide. 
To the required iodide (2.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 3-amino-2-
thiophenecarboxylate (0.16 g, 1.0 mmol) and K2CO3 (0.28 g, 2.0 mmol). 
The mixture was degassed and heated at 140 °C under argon for 24 h. 
During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was added 
after 2, 4, 6 and 8 h of heating. After cooling to room temperature, the 
mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3 x 10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (the eluent is given in the 
product description) led to the expected compound. 
Methyl 3-(diphenylamino)-2-thiophenecarboxylate (10a). 
The general procedure 7 using iodobenzene (0.22 mL) gave 10a (eluent: 
hexanes-AcOEt 95:5; Rf = 0.35) in 88% yield (0.27 g) as a yellow oil; IR 
(ATR): 503, 583, 637, 674, 694, 754, 776, 853, 951, 1041, 1074, 1094, 
1175, 1226, 1253, 1394, 1418, 1438, 1481, 1524, 1567, 1592, 1667, 
1714, 2950 cm-1; 1H NMR (300 MHz, CDCl3)  3.53 (s, 3H, OMe), 6.81 (d, 
1H, J = 5.3 Hz, H4), 7.00 (t, 2H, J = 7.2 Hz, H4’), 7.04 (d, 4H, J = 8.1 Hz, 
H2’ and H6’), 7.23 (t, 4H, J = 7.8 Hz, H3’ and H5’), 7.42 (d, 1H, J = 5.3 
Hz, H5); 13C NMR (75 MHz, CDCl3)  51.7 (CH3), 121.1 (C, C2), 122.7 
(4CH, C2’ and C6’), 122.9 (2CH, C4’), 128.6 (CH), 129.1 (4CH, C3’ and 
C5’), 130.3 (CH), 147.7 (2C, C1’), 149.8 (C, C3), 161.3 (C, C=O). HRMS 
(EI) m/z calcd for C18H15NO2S: 309.0823; found: 309.0820. 
Methyl 3-(di(3-thienyl)amino)-2-thiophenecarboxylate (10d). 
The general procedure 7 using 3-iodothiophene (0.20 mL) gave 10d 
(eluent: hexanes-AcOEt 90:10; Rf = 0.52) in 87% yield (0.28 g) as a 
yellow oil; IR (ATR): 605, 626, 649, 726, 749, 761, 841, 914, 986, 1042, 
1073, 1099, 1151, 1188, 1214, 1297, 1375, 1401, 1423, 1437, 1520, 
1692, 1713, 2947, 3105 cm-1; 1H NMR (300 MHz, CDCl3)  3.59 (s, 3H, 
OMe), 6.58 (dd, 2H, J = 3.1 and 1.2 Hz, H2’), 6.86 (dd, 2H, J = 5.2 and 
1.2 Hz, H4’), 6.88 (d, 1H, J = 5.6 Hz, H4), 7.18 (dd, 2H, J = 5.2, 3.2 Hz, 
H5’), 7.40 (d, 1H, J = 5.3 Hz, H5); 13C NMR (75 MHz, CDCl3)  51.8 
(CH3), 109.7 (2CH), 120.0 (C), 123.3 (2CH), 124.8 (2CH), 127.3 (CH), 
130.2 (CH), 146.8 (2C, C3’), 149.9 (C), 161.4 (C, C=O). HRMS (EI) m/z 
calcd for C14H11NO2S3: 320.9952; found: 320.9957. Methyl 3-(3-
thienylamino)-2-thiophenecarboxylate (9d) was similarly isolated 
(eluent: hexanes-AcOEt 90:10; Rf = 0.575) in <10% yield as a yellow oil: 
IR (ATR): 455, 584, 610, 722, 770, 840, 958, 1035, 1083, 1238, 1350, 
1402, 1424, 1444, 1556, 1571, 1661, 2949, 3103, 3330 cm-1; 1H NMR 
(300 MHz, CDCl3)  3.86 (s, 3H, OMe), 6.82 (dd, 1H, J = 3.2, 1.4 Hz, H2’), 
6.95 (dd, 1H, J = 5.2, 1.4 Hz, H4’), 7.03 (d, 1H, J = 5.5 Hz, H4), 7.27 (dd, 
1H, J = 5.1, 3.1 Hz, H5’), 7.36 (d, 1H, J = 5.5 Hz, H5), 8.75 (br s, 1H, 
NH); 13C NMR (75 MHz, CDCl3)  51.5 (CH3), 102.0 (C), 109.1 (CH), 
118.0 (CH), 123.4 (CH), 125.5 (CH), 132.1 (CH), 140.4 (C), 152.4 (C), 
165.3 (C).  
General procedure 8 for the N-arylation of methyl 3-(phenylamino)-
2-thiophenecarboxylate (9a). 
To the required iodide (1.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 3-(phenylamino)-2-
thiophenecarboxylate (9a, 0.23 g, 1.0 mmol) and K2CO3 (0.28 g, 
2.0 mmol). The mixture was degassed and heated at 140 °C under argon 
for 24 h. During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was 
    
 
 
 
 
 
added after 2, 4, 6 and 8 h of heating. After cooling to room temperature, 
the mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3 x 10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (the eluent is given in the 
product description) led to the expected compound. 
Methyl N-(4-methoxyphenyl)-N-phenyl-3-amino-2-
thiophenecarboxylate (10ab). The general procedure 8 using 4-
iodoanisole (0.23 g) gave 10ab (eluent: hexanes-AcOEt 95:5; Rf = 0.27) 
in 91% yield (0.31 g) as a yellow powder: mp 122 °C; IR (ATR): 665, 693, 
720, 747, 769, 779, 789, 805, 836, 1026, 1041, 1073, 1098, 1225, 1247, 
1258, 1442, 1489, 1505, 1594, 1709, 2922, 2957 cm-1; 1H NMR (300 
MHz, CDCl3)  3.53 (s, 3H, OMe), 3.79 (s, 3H, OMe), 6.77 (d, 1H, J = 5.4 
Hz, H4), 6.81 (d, 2H, J = 9.0 Hz), 6.90-6.95 (m, 3H, H2’, H4’ and H6’), 
7.03 (d, 2H, J = 8.9 Hz), 7.19 (t, 2H, J = 7.9 Hz, H3’ and H5’), 7.39 (d, 1H, 
J = 5.4 Hz, H5); 13C NMR (75 MHz, CDCl3)  51.7 (CH3), 55.6 (CH3), 
114.6 (2CH), 119.9 (C), 121.1 (2CH), 122.0 (CH), 125.8 (2CH), 128.3 
(CH), 129.0 (2CH), 130.2 (CH), 140.8 (C), 148.6 (C), 150.2 (C), 156.3 (C), 
161.3 (C); HRMS (EI) m/z calcd for C19H17NO3S: 339.0929; found: 
339.0926. Crystal data for 10ab. C19H17NO3S, M = 339.39, triclinic, P -1, 
a = 9.2351(10), b = 9.7922(11), c = 9.9542(11) Å, α = 102.222(4), β = 
96.641(4), γ = 108.875(4) °, V = 815.80(16) Å3, Z = 2, d = 1.382 g cm-3, μ 
= 0.215 mm-1. A final refinement on F2 with 3725 unique intensities and 
219 parameters converged at ωR(F2) = 0.0824 (R(F) = 0.0333) for 3289 
observed reflections with I > 2σ(I). CCDC 1896368. 
Methyl N-phenyl-N-(4-(trifluoromethyl)phenyl)-3-amino-2-
thiophenecarboxylate (10ac). The general procedure 8 using 1-iodo-4-
(trifluoromethyl)benzene (0.15 mL) gave 10ac (eluent: hexanes-AcOEt 
95:5; Rf = 0.40) in 94% yield (0.35 g) as a yellow oil: IR (ATR): 508, 522, 
611, 646, 684, 698, 732, 749, 769, 838, 951, 1011, 1040, 1066, 1110, 
1161, 1183, 1226, 1279, 1297, 1316, 1396, 1438, 1490, 1515, 1528, 
1591, 1614, 1715, 2951 cm-1; 1H NMR (300 MHz, CDCl3)  3.59 (s, 3H, 
OMe), 6.87 (d, 1H, J = 5.3 Hz, H4), 7.03 (d, 2H, J = 8.5 Hz), 7.09-7.15 (m, 
3H), 7.31 (t, 2H, J = 7.8 Hz, H3’ and H5’), 7.45 (d, 2H, J = 8.6 Hz), 7.50 
(d, 1H, J = 5.3 Hz, H5); 13C NMR (75 MHz, CDCl3)  51.8 (CH3), 119.9 
(2CH), 123.1 (C), 123.2 (q, C, J = 32.4 Hz, C4”), 124.2 (2CH), 124.5 (CH), 
124.6 (q, C, J = 269 Hz, CF3), 126.2 (q, 2CH, J = 3.7 Hz, C3” and C5”), 
128.7 (CH), 129.4 (2CH), 130.9 (CH), 146.2 (C), 148.5 (C), 150.8 (d, C, J 
= 1.3 Hz), 160.9 (C). HRMS (EI) m/z calcd for C19H14F3NO2S: 377.0697; 
found: 377.0698. 
Methyl 2-(phenylamino)-3-thiophenecarboxylate (11a). To 
iodobenzene (0.11 mL, 1.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 2-amino-3-
thiophenecarboxylate (0.16 g, 1.0 mmol) and K2CO3 (0.28 g, 2.0 mmol). 
The mixture was degassed and heated at 140 °C under argon for 24 h. 
During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was added 
after 2, 4, 6 and 8 h of heating. After cooling to room temperature, the 
mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3 x 10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (eluent: hexanes-AcOEt 
95:5; Rf = 0.50) afforded 11a in 83% yield (0.19 g) as a white powder: mp 
64 °C (lit.[37] 59-60 °C); IR (ATR): 490, 503, 661, 684, 751, 782, 1012, 
1084, 1154, 1193, 1241, 1337, 1382, 1407, 1440, 1498, 1509, 1553, 
1592, 1670, 2948, 3213 cm-1; 1H NMR (300 MHz, CDCl3)  3.87 (s, 3H, 
OMe), 6.31 (d, 1H, J = 5.7 Hz), 7.07 (t, 1H, J = 7.1 Hz, H4’), 7.15 (d, 1H, 
J = 5.8 Hz), 7.31 (d, 2H, J = 7.6 Hz, H2’ and H6’), 7.37 (t, 2H, J = 7.8 Hz, 
H3’ and H5’), 9.91 (br s, 1H, NH); 13C NMR (75 MHz, CDCl3)  51.3 
(CH3), 107.1 (CH), 107.5 (C), 118.2 (2CH), 122.9 (CH), 125.4 (CH), 
129.5 (2CH), 140.9 (C), 158.5 (C), 166.4 (C). These data are similar to 
those described previously.[37] 
General procedure 9 for the bis-N-arylation of methyl 2-amino-3-
thiophenecarboxylate using the same iodide. 
To the required iodide (2.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 2-amino-3-
thiophenecarboxylate (0.16 g, 1.0 mmol) and K2CO3 (0.28 g, 2.0 mmol). 
The mixture was degassed and heated at 140 °C under argon for 24 h. 
During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was added 
after 2, 4, 6 and 8 h of heating. After cooling to room temperature, the 
mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3 x 10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (the eluent is given in the 
product description) led to the expected compound. 
Methyl 2-(diphenylamino)-3-thiophenecarboxylate (12a). 
The general procedure 9 using iodobenzene (0.22 mL) gave 12a (eluent: 
hexanes-AcOEt 95:5; Rf = 0.27) in 54% yield (0.17 g) as a yellow 
powder: mp 110 °C; 1H NMR (300 MHz, CDCl3)  3.52 (s, 3H, OMe), 
6.98 (d, 1H, J = 5.9 Hz), 7.03 (t, 2H, J = 7.5 Hz, H4’), 7.08 (d, 4H, J = 7.9 
Hz, H2’ and H6’), 7.25 (t, 4H, J = 7.8 Hz, H3’ and H5’), 7.33 (d, 1H, J = 
5.9 Hz); 13C NMR (75 MHz, CDCl3)  51.4 (CH3), 120.1 (CH), 122.5 
(4CH), 123.2 (2CH), 124.7 (C), 128.2 (CH), 129.1 (4CH), 147.9 (2C), 
156.8 (C), 162.5 (C). HRMS (EI) m/z calcd for C18H15NO2S: 309.0823; 
found: 309.0819. 
Methyl 2-(di(3-thienyl)amino)-3-thiophenecarboxylate (12d). 
The general procedure 9 using 3-iodothiophene (0.20 mL) gave 12d 
(eluent: hexanes-AcOEt 90:10; Rf = 0.52) in 76% yield (0.24 g) as a 
yellow oil: IR (ATR): 472, 601, 630, 637, 668, 694, 734, 761, 782, 829, 
836, 846, 871, 970, 997, 1072, 1083, 1129, 1148, 1185, 1237, 1256, 
1285, 1383, 1395, 1453, 1522, 1537, 1695, 2949, 3104 cm-1; 1H NMR 
(300 MHz, CDCl3)  3.59 (s, 3H, OMe), 6.64 (d, 2H, J = 2.4 Hz, H2’), 6.89 
(d, 2H, J = 5.2 Hz, H4’), 6.93 (d, 1H, J = 5.9 Hz), 7.18 (dd, 2H, J = 5.1 
and 3.2 Hz, H5’), 7.32 (d, 1H, J = 5.9 Hz); 13C NMR (75 MHz, CDCl3)  
51.3 (CH3), 109.9 (2CH), 119.4 (CH), 122.7 (2CH), 123.6 (C), 124.8 
(2CH), 127.9 (CH), 146.7 (C), 156.5 (C), 162.2 (C). HRMS (EI) m/z calcd 
for C14H11NO2S3: 320.9952; found: 320.9948.  
General procedure 10 for the N-arylation of methyl 2-(phenylamino)-
3-thiophenecarboxylate (11a) 
To the required iodide (1.0 mmol) in Bu2O (1.5 mL) were successively 
added activated Cu (13 mg, 0.20 mmol), methyl 2-(phenylamino)-3-
thiophenecarboxylate (11a, 0.23 g, 1.0 mmol) and K2CO3 (0.28 g, 
2.0 mmol). The mixture was degassed and heated at 140 °C under argon 
for 24 h. During this time, activated Cu (4 x 13 mg, 4 x 0.20 mmol) was 
added after 2, 4, 6 and 8 h of heating. After cooling to room temperature, 
the mixture was concentrated. Addition of H2O (25 mL), extraction with 
AcOEt (3 x 10 mL), drying over Na2SO4, removal of the solvent and 
purification by chromatography on silica gel (the eluent is given in the 
product description) led to the expected compound. 
Methyl N-(4-methoxyphenyl)-N-phenyl-2-amino-3-
thiophenecarboxylate (12ab). 
The general procedure 10 using 4-iodoanisole (0.23 g) gave 12ab 
(eluent: hexanes-AcOEt 90:10; Rf = 0.25) in 86% yield (0.29 g) as a red 
oil: IR (ATR): 533, 570, 614, 632, 645, 694, 750, 823, 910, 1003, 1033, 
1084, 1108, 1144, 1191, 1238, 1284, 1387, 1438, 1463, 1490, 1506, 
1531, 1594, 1704, 2835, 2949 cm-1; 1H NMR (300 MHz, CDCl3)  3.55 (s, 
3H, OMe), 3.79 (s, 3H, OMe), 6.86 (d, 2H, J = 8.9 Hz, H2” and H6”), 6.91 
    
 
 
 
 
 
(d, 1H, J = 5.9 Hz), 6.95-6.99 (m, 3H), 7.15 (d, 2H, J = 8.9 Hz, H3” and 
H5”), 7.18-7.24 (m, 2H), 7.32 (d, 1H, J = 5.9 Hz); 13C NMR (75 MHz, 
CDCl3)  51.2 (CH3), 55.4 (CH3), 114.5 (2CH), 119.3 (CH), 120.3 (2CH), 
121.9 (CH), 123.4 (C), 125.8 (2CH), 128.0 (CH), 128.9 (2CH), 140.7 (C), 
148.6 (C), 156.6 (C), 157.5 (C), 162.3 (C) ; HRMS (EI) m/z calcd for 
C19H17NO3S: 339.0929; found: 339.0932. 
Methyl N-(2-benzofuryl)-N-phenyl-2-amino-3-thiophenecarboxylate 
(12ae). 
The general procedure 10 using 2-iodobenzofuran (0.24 g) gave 12ae 
(eluent: hexanes-AcOEt 90:10; Rf = 0.425) in 53% yield (0.18 g) as an 
orange oil: IR (ATR): 486, 501, 692, 708, 744, 764, 828, 908, 971, 1006, 
1084, 1105, 1153, 1152, 1211, 1248, 1281, 1342, 1389, 1437, 1452, 
1492, 1536, 1582, 1709, 2949, 3062 cm-1; 1H NMR (300 MHz, CDCl3)  
3.61 (s, 3H, OMe), 6.11 (s, 1H, H3”), 7.09 (d, 1H, J = 5.9 Hz), 7.11-7.22 
(m, 5H), 7.31-7.39 (m, 3H), 7.42-7.45 (m, 2H); 13C NMR (75 MHz, CDCl3) 
 51.6 (CH3), 91.8 (CH), 110.7 (CH), 119.8 (CH), 121.1 (2CH), 121.2 
(CH), 122.8 (CH), 123.1 (CH), 124.0 (CH), 125.9 (C), 128.2 (CH), 129.2 
(2CH), 129.3 (C), 145.6 (C), 151.3 (C), 152.5 (C), 155.2 (C), 162.2 (C). 
HRMS (EI) m/z calcd for C20H15NO3S: 349.0773; found: 349.0770. 
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